NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR A SOLICITATION TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN IN WHICH SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL OR TO ANY PERSON TO WHOM IT IS UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NEITHER THIS ANNOUNCEMENT NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY SUCH JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF THE LAW OF ENGLAND AND WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

18 May 2023

Velocys plc

("Velocys", the "Company" or the "Group")

Proposed Placing, Retail Offer and Open Offer

Proposed conditional issue of Convertible Loan Notes led by strategic investor, Carbon Direct Capital

Placing, Retail Offer and Open Offer to provide funds through expected key value inflection points for the Company in relation to the Altalto Project and Bayou Fuels Project

Additional capital raise to support significant scale-up and ambition to become a leading provider of Sustainable Aviation Fuel solutions

Velocys plc (AIM: VLS) (the "Company"), the sustainable fuels technology company, announces its intention to raise approximately £6 million in aggregate before expenses by way of a conditional Placing (the "Placing") at the price of 2.5 pence per Placing Share (the "Issue Price") together with a retail offer to existing retail Shareholders on the BookBuild Platform at the Issue Price (the "Retail Offer"). The Company is also announcing  an open offer of new Ordinary Shares at the Issue Price (the "Open Offer") and a proposed conditional issue of convertible loan notes ("Convertible Loan Notes") to Carbon Direct Capital, and potential further issuances of Convertible Loan Notes and/or new Ordinary Shares to investors other than Carbon Direct Capital (together with the Placing and Retail Offer the "Fundraise").

The Placing will be effected through the issue of new Ordinary Shares (the "Placing Shares") to new and existing investors.

The Retail Offer will be for up to 20,000,000 new Ordinary Shares at the Issue Price on the BookBuild Platform (the "Retail Offer Shares") to raise up to approximately £0.5 million (before expenses) to provide existing retail Shareholders in the United Kingdom with an opportunity to participate in the Fundraise. A separate announcement will be made in due course regarding the Retail Offer and its terms. For the avoidance of doubt, the Retail Offer is not part of the Placing.

In order to provide Shareholders who have not taken part in the Placing or the Retail Offer with an opportunity to participate in the proposed Fundraise, the Company is also offering Eligible Shareholders the opportunity to subscribe, at the Issue Price, for an aggregate of up to 77,648,390 new Ordinary Shares (the "Open Offer Shares"), to raise up to approximately £2 million via the Open Offer.

Strategic investor, Carbon Direct Capital, has conditionally agreed to subscribe for a minimum of $15 million (approximately £12 million) of the Convertible Loan Notes subject to, inter alia, the Company raising or having received legally binding commitments in respect of the Minimum Amount. Further details on the terms of the Convertible Loan Notes are set out in paragraph 6 of Appendix I.

Carbon Direct Capital, which is based in New York, US, is a growth investment firm focused on carbon management technologies. Carbon Direct Capital believes that selective investing with a scientific approach maximises both climate benefits and financial returns. Carbon Direct Capital has partnered with a number of transformative carbon tech companies across two growth equity funds and is the lead investor in the proposed conditional issue of the Convertible Loan Notes. Carbon Direct Capital's subscription of a minimum of $15 million of the Convertible Loan Notes will become unconditional provided that, among other things, the Minimum Amount Condition is satisfied, by the CLN Long Stop Date.

The Convertible Loan Notes are unsecured and have been structured to incentivise a US Listing of the Company, in addition to its existing admission to trading on AIM, within 21 months from the date of completion of the issuance of Convertible Loan Notes to Carbon Direct Capital ("US Listing"). A number of discussions are underway with additional potential Convertible Loan Note investors.

Funds raised through the Placing, the Retail Offer and the Open Offer will be used primarily to provide growth capital in preparation for significant scale-up and working capital through expected key valuation inflection points for the Altalto Project and the Bayou Fuels Project with additional funds intended to be raised through the issue of the Convertible Loan Notes to Carbon Direct Capital and potential further issuances of Convertible Loan Notes and/or New Ordinary Shares to drive the Company's technology delivery capability and to provide balance sheet strength whilst continuing to build a revenue generating pipeline.

Placing, Retail Offer and Open Offer Highlights

·      The Placing will be conducted by way of an accelerated bookbuild process at the Issue Price (the "Bookbuild"), which will be launched immediately following this announcement in accordance with the terms and conditions set out in Appendix II.

·      The Company is also launching a Retail Offer to eligible existing retail Shareholders at the Issue Price and a separate announcement regarding the Retail Offer will be made shortly.

·      Subject to the successful closing of the Bookbuild, the Company is also making an Open Offer, for up to 77,648,390 Open Offer Shares, to raise up to approximately £2 million at the Issue Price, on the basis of 1 Open Offer Share for every 18 Existing Ordinary Shares held by Eligible Shareholders at the Record Date. Any entitlements to Open Offer Shares not subscribed for by Eligible Shareholders will be available to Eligible Shareholders under an excess application facility for the Open Offer.

·      It is expected that certain Directors and senior management in the Company will subscribe for New Ordinary Shares through the Placing for an aggregate amount of approximately £75,000. Further details will be announced as appropriate in due course. 

Convertible Loan Notes Highlights

·      Proposed conditional issue of Convertible Loan Notes of which, to date, $15 million (approximately £12 million) have been conditionally subscribed for by Carbon Direct Capital.

·      Ongoing discussions with potential strategic co-investors in the Convertible Loan Notes.

·      Issue of the Convertible Loan Notes to Carbon Direct Capital is conditional on, amongst other things, the Company having raised or having received legally binding commitments in respect of the Minimum Amount from the Fundraise.

·      The Convertible Loan Notes have been structured to incentivise a US Listing of the Company, in addition to its existing admission to trading on AIM, within 21 months from completion of the issuance of Convertible Loan Notes to Carbon Direct Capital.

·      The Convertible Loan Notes convert into new Ordinary Shares upon a US Listing, or earlier as may be elected by the CLN Investors, at a conversion price equivalent to the Issue Price, which may be adjusted downwards in the event that the Company undertakes a further equity raise at a lower subscription price per share prior to Conversion.

·      The Convertible Loan Notes are unsecured and have zero coupon for the first 21 months from issue. If the Company achieves a US Listing within this 21-month period or the Convertible Loan Notes are otherwise redeemed or converted by such date, the Convertible Loan Notes will not bear interest. If not, an annualised interest rate of 12.5 per cent. will apply from the date of issuance of the Convertible Loan Notes which shall accrue in varying monthly coupons.

Use of Proceeds

·      The net proceeds of the Placing, the Retail Offer and the Open Offer will be used primarily for:

o  organisation costs including project delivery and business development;

o  engineering scale-up with investment in engineering resource;

o  initial commissioning of the Ohio manufacturing facility; and

o  working capital requirements to invest in achieving supply chain resilience and to cover timeline of grant receipts.

·      In the event of the Minimum Amount being raised, the net proceeds of the issuance of the Convertible Loan Notes to Carbon Direct Capital and the issuance of further Convertible Loan Notes and/or Ordinary Shares to investors other than Carbon Direct Capital will be used primarily for:

o  scaling-up of the organisation and corporate costs including increasing labour from approximately 40 full time employees to approximately 100 full time employees gradually over the next 12 to 18 months in line with client and project demand in order to accelerate the capability of the Company to deliver its technology to its clients at scale;

o  completion of capital investment in the Ohio reactor core manufacturing facility including production start-up and catalysis upgrades;

o  funding for US Listing costs or interest payments due on the Convertible Loan Notes in the event no US Listing occurs during the 21-month period from issue of the Convertible Loan Notes;

o  supporting performance guarantees for the Company's proprietary Fischer-Tropsch technology to be delivered to client projects; and

o  working capital requirements, build-up of reactor inventory at the Ohio manufacturing facility and to manage timing of payments and grant receipts.

Company Highlights

·      Velocys is an international sustainable fuels technology company with patented technology enabling scalable production of drop-in, net zero, sustainable aviation fuel ("SAF").

·      It delivers a competitive and commercially demonstrated Fischer-Tropsch Synthesis solution using solid feedstocks or hydrogen from renewable power and CO₂.

·      Velocys' conversion pathway enables negative carbon intensity fuels via CO₂ sequestration of between 30 per cent. and 40 per cent. of the feedstock carbon used.

·      Capital light, scalable licensing model with revenues from technology licencing, engineering services, and Company reactor and catalyst supply over the lifetime of refineries. The Company generates both upfront and recurring fees.

·      High growth market driven by decarbonisation mandates and incentives with increasing policy support (UK, US, Europe, Canada).

·      Accelerating its commercialisation strategy by advancing two full-scale biorefinery Reference Projects (Altalto Project in the UK and the Bayou Fuels Project in the US) to generate significant revenue for the Company and accelerate technology adoption. The Reference Projects provide a blueprint for future customers.

·      Appointment of Bechtel, a leading worldwide provider of engineering, construction and project management services, as SAF project delivery partner to provide front end project engineering and other technical services to Velocys' SAF project portfolio.

·      Significant progress of the Bayou Fuels Project:

o  highly favourable US climate legislation announced in the second half of 2022;

o  appointment of a leading global investment bank to lead funding for project development capital which is expected to close during the last quarter of 2023;

o  project economics significantly enhanced following improved carbon intensity score through the provision of biomass boiler renewable power solution with carbon capture integration; and

o  100 per cent. of expected project SAF output is subject to an offtake agreement or memorandum of understanding for offtake.

·      Significant progress of the Altalto Project:

o  £27 million grant from the UK Department for Transport (DfT) awarded in December 2022 under the Advanced Fuels Fund and consequential commencement of Front End Engineering Design; and

o  appointment of a leading global investment bank to lead the matched funding capital raise required for the DfT grant. The project fundraise is expected to close during the last quarter of 2023.

·      The business development pipeline continues to grow, with a number of feasibility studies underway with both biorefinery and advanced power-to-liquid developers, as well as a significant increase in enquiries for potential projects. The Company expects to move forward with a number of new clients over the course of 2023.

·      Engineering services contract with Toyo in Japan continues.

·      Construction of the Company's new reactor core manufacturing facility in Columbus, Ohio has been completed, with commissioning commencing in the second half of 2023. This will significantly increase the Company's capacity to deliver Fischer-Tropsch synthesis technology solutions to its clients.

Henrik Wareborn, Chief Executive of Velocys, said:

"There is global recognition of the urgent need to replace fossil derived fuels with sustainable equivalents in order to tackle climate change. Velocys provides a unique technological pathway to the economic production of drop-in sustainable aviation fuel, which can decarbonise the aviation industry without the need for any aircraft engine modification. Put simply: we believe that we have a ready-to-go solution to the challenge of making aviation environmentally sustainable. The commitment from Carbon Direct Capital, which has partnered with a number of transformative carbon tech companies, to conditionally subscribe for a minimum of $15 million of convertible loan notes provides further demonstration of the increasing global awareness and expert validation of Velocys' proprietary technology.

"We have a highly scalable business model, partnerships with some of the world's leading technology companies and airlines, and a growing business development pipeline. We are well-positioned now to move on to the next stage of our growth, and we are excited by what the future has in store.

"Our ambition is to become a leading provider of innovative SAF solutions to enable the decarbonisation of the aviation industry."

Further details relating to the Fundraise

The Issue Price of 2.5 pence per New Ordinary Share represents a discount of 26.9 per cent. to the closing mid-market price of 3.42 pence per Existing Ordinary Share as at 17 May 2023.

The Placing Shares are not being made available to the public. It is envisaged that the Bookbuild will be closed no later than 11.00 a.m. GMT tomorrow, 19 May 2023 but may be closed earlier, or later, at the discretion of the Joint Bookrunners. Details of the number of Placing Shares will be announced as soon as practicable after the closing of the Bookbuild (on 19 May 2023). The Placing, the Retail Offer and the Open Offer are not underwritten.

The Fundraise is conditional on, inter alia, the passing of the Resolutions by the Shareholders at the General Meeting to be held at 10.30 a.m. on 8 June 2023 at Magdalen Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford OX4 4GA. The Placing, the Retail Offer and the Open Offer are not conditional on the issue of the Convertible Loan Notes or on the Minimum Amount being raised. The Retail Offer and the Open Offer are conditional upon completion of the Placing. The Placing is not conditional upon any of the Retail Offer, the Open Offer, the issue of the Convertible Loan Notes or any future fundraise to raise the Minimum Amount. Subscription by Carbon Direct Capital for Convertible Loan Notes is conditional on the Company having raised or having received legally binding commitments in respect of the Minimum Amount from the Fundraise. Should Shareholder approval for the Resolutions relating to the Placing, the Retail Offer and the Open Offer not be obtained at the General Meeting, none of the Placing, the Retail Offer or the Open Offer will proceed. Should Shareholder approval for all Resolutions not be obtained at the General Meeting, the proposed conditional issue of Convertible Loan Notes to Carbon Direct Capital and/or other investors will not proceed. The Placing, Retail Offer and Open Offer are not conditional on the passing of the Resolutions relating to the Convertible Loan Notes.

Set out below in Appendix I is an adapted extract from the Circular that is proposed to be sent to Shareholders after the closure of the Bookbuild and which provides further information on the Company, the Placing, the Retail Offer, the Open Offer and the proposed conditional issuance of the Convertible Loan Notes. The final Circular, containing the terms and conditions of the Open Offer and Notice of General Meeting will be sent to Shareholders and published on the Company's website on or around 22 May 2023.

Terms and conditions of the Bookbuild are set out in Appendix II.

The capitalised terms not otherwise defined in the text of this announcement are defined in Appendix III and the expected timetable of the principal events is set out in Appendix IV.

This summary should be read in conjunction with the full text of the following announcement.

Enquiries:

Notes to Editors

About Velocys

Velocys is an AIM quoted, international sustainable fuels technology company, providing customers with a technology solution to enable the production of negative Carbon Intensity synthetic, drop-in fuels from a variety of waste materials. Synthetic fuel is the only commercially available, permanent alternative to fossil aviation fuels. The Velocys technology is IP-protected in all major jurisdictions.

Two reference projects in the US and UK (Bayou Fuels and Altalto respectively) are designed to accelerate the adoption and standardise the Velocys proprietary Fischer Tropsch (FT) technology with an integrated end to end solution, including renewable power and sequestration.

Velocys is enabling commercial scale synthetic fuel production in response to the clean energy transition, with significant additional positive air quality impacts.

www.velocys.com

About Carbon Direct Capital

Carbon Direct Capital is a New York, US, based growth investment firm focused on carbon management technologies. The firm believes that selective investing with a science focused approach maximizes both climate impact and financial returns. Carbon Direct Capital has partnered with a number of transformative carbon tech companies across two growth equity funds. To learn more, visit www.carbondirectcapital.com.

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW.

IMPORTANT NOTICES

IMPORTANT NOTICE

The information contained in this announcement is for information purposes only and does not purport to be full or complete. The information contained in this announcement is given at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment from time to time. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

Neither this announcement, nor any copy of it, may be taken or transmitted, published or distributed, directly or indirectly, in or into any jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction. This announcement is for information purposes only and does not constitute an offer to sell or issue, or the solicitation of an offer to buy, acquire or subscribe for any shares in the Company in any state or jurisdiction in which such offer or solicitation is not authorised or to any person to whom it is unlawful to make such offer or solicitation. Any failure to comply with these restrictions may constitute a violation of securities laws of such jurisdictions.

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.  This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act"), and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

The contents of this announcement have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the Placing. If you are in any doubt about any of the contents of this announcement, you should obtain independent professional advice. This is not an offer to the public and the Placing Documents (as defined below) will not be registered as a prospectus under the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the laws of Hong Kong) or any other applicable ordinance in Hong Kong.

This announcement must not, therefore, be distributed, issued, circulated or possessed for the purpose of distribution or issue or circulation, to persons in Hong Kong other than (1) to professional investors within the meaning of the Securities and Futures Ordinance (Cap. 571 of the laws of Hong Kong) (including professional investors falling within the Securities and Futures (Professional Investors) Rules (Cap. 571D of the laws of Hong Kong)) or (2) in circumstances which would not constitute an offer to the public for the purpose of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the laws of Hong Kong) or the Securities and Futures Ordinance (Cap. 571 of the laws of Hong Kong).

This announcement has been issued by, and is the sole responsibility of, the Company. No undertaking, representation, warranty or other assurance, express or implied, is made or given by or on behalf of the Company, Panmure Gordon (UK) Limited ("Panmure Gordon") or Shore Capital Stockbrokers Limited ("Shore Capital") or any of their respective directors, officers, partners, employees, agents or advisers or any other person as to the accuracy or completeness of the information or opinions contained in this announcement and no responsibility or liability is accepted by any of them for any such information or opinions or for any errors, omissions or misstatements, negligence or otherwise in this announcement.

Panmure Gordon is authorised and regulated in the UK by the FCA and is acting as nominated adviser and joint broker to the Company. Panmure Gordon is not acting for, and will not be responsible to, any person other than the Company for providing the protections afforded to its customers or for advising any other person on the contents of this announcement or on any transaction or arrangement referred to in this announcement. No representation or warranty, express or implied, is made by Panmure Gordon as to, and no liability is accepted by Panmure Gordon in respect of, any of the contents of this announcement. The responsibilities of Panmure Gordon as the Company's nominated adviser under the AIM Rules for Companies ("AIM Rules") and the AIM Rules for Nominated Advisers are owed solely to London Stock Exchange plc and are not owed to the Company or to any director or Shareholder of the Company or any other person, in respect of his decision to acquire shares in the capital of the Company in reliance on any part of this announcement, or otherwise.

Shore Capital is authorised and regulated in the UK by the FCA and is acting as joint broker to the Company. Shore Capital is not acting for, and will not be responsible to, any person other than the Company for providing the protections afforded to its customers or for advising any other person on the contents of this announcement or on any transaction or arrangement referred to in this announcement. No representation or warranty, express or implied, is made by Shore Capital as to, and no liability is accepted by Shore Capital in respect of, any of the contents of this announcement.

The information in this announcement may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. Any forwarding, distribution, reproduction, or disclosure of this information in whole or in part is unauthorised. Failure to comply with this directive may result in a violation of applicable securities laws and regulations of other jurisdictions.

This announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company's current expectations and projections about future events and the Company's future financial condition and performance. These statements, which sometimes use words such as "aim", "anticipate", "believe", "may", "will", "should", "intend", "plan", "assume", "estimate", "expect" (or the negative thereof) and words of similar meaning, reflect the current beliefs and expectations of the directors of the Company and/or the Joint Bookrunners and involve known and unknown risks, uncertainties and assumptions, many of which are outside the Company's control and difficult to predict, that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement. The information contained in this announcement speaks only as of the date of this announcement and is subject to change without notice and the Company does not assume any responsibility or obligation to, and does not intend to, update or revise publicly or review any of the information contained to this announcement, whether as a result of new information, future events or otherwise, except to the extent required by the FCA, the London Stock Exchange or by applicable law.

Any information in this announcement in respect of past performance (including without limitation past performance of the Company, its group, shares in the Company and/or the Company's portfolio) cannot be relied upon as a guide to future performance. The price of shares and the income from them may fluctuate upwards or downwards and cannot be guaranteed.

This announcement contains inside information as defined in Regulation (EU) No. 596/2014 on market abuse which is part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is made in accordance with the Company's obligations under article 17 of MAR. The person responsible for arranging the release of this announcement on behalf of Velocys is David Bate, General Counsel of Velocys.

APPENDIX I

The Fundraise

1.         Introduction

The Company proposes to raise, subject to certain conditions: (i) approximately £6 million (before expenses) in aggregate by way of a conditional Placing of new Ordinary Shares at the Issue Price to certain institutional and other investors and by way of a Retail Offer to eligible retail Shareholders through the issue of up to 20,000,000 Retail Offer Shares at the Issue Price on the BookBuild Platform (details of which will be announced in a separate announcement in due course); and (ii) up to approximately £2 million (before expenses) by way of an Open Offer made to Eligible Shareholders of up to 77,648,390 Open Offer Shares at the Issue Price. The Issue Price represents a discount of 26.9 per cent. to the closing mid-market price of the Ordinary Shares as at 17 May 2023 of 3.42 pence per Ordinary Share.

In addition, the Company intends to raise a minimum of $15 million (approximately £12 million) through the proposed issue of Convertible Loan Notes to Carbon Direct Capital and further amounts to satisfy the Minimum Amount Condition through potential further issuances of Convertible Loan Notes and/or new Ordinary Shares to investors other than Carbon Direct Capital. This strategic investment in the Convertible Loan Notes is being led by Carbon Direct Capital which has entered into the Commitment Letter for the proposed subscription and issue by the Company, subject to the satisfaction of the conditions set out therein, of Convertible Loan Notes with a subscription value of $15 million (approximately £12 million). The maximum amount that may be raised by the Company pursuant to the Fundraise is £50 million.

Carbon Direct Capital is a New York, US, based growth investment firm focused on carbon management technologies. The firm believes that selective investing with a scientific approach maximises both climate benefits and financial returns. Carbon Direct Capital has partnered with a number of transformative carbon tech companies across two growth equity funds.

The Convertible Loan Notes are structured to incentivise a US Listing of the Company, in addition to its existing admission to trading on AIM. The Convertible Loan Notes are unsecured and automatically convert into Ordinary Shares at the Conversion Price upon US Listing. The Convertible Loan Notes will not bear interest, provided that Velocys achieves a US Listing prior to the 21-month anniversary of the issue of the Convertible Loan Notes. Further details on the terms of the Convertible Loan Notes are set out in paragraph 6 of this Appendix I. Discussions are ongoing with additional potential Convertible Loan Note investors.

The Directors have been considering the merits of a US Listing for some time, given Velocys' Bayou Fuels Project and technical centre in the US, favourable pro-sustainable fuels legislation, and the large number of US specialist institutional investors. The Directors believe that a dual listing will further enhance the Company's reputation and increase global awareness of the Company's proprietary technology. This funding provides the impetus and support for progressing these plans.

Funds raised through the Placing, the Retail Offer and the Open Offer will be used primarily to provide growth capital in preparation for significant scale-up and working capital through expected key valuation inflection points for the Altalto Project and Bayou Fuels Project with additional funds intended to be raised through the issue of the Convertible Loan Notes to Carbon Direct Capital and potential further issuances of Convertible Loan Notes and/or new Ordinary Shares to investors other than Carbon Direct Capital to drive the Company's technology delivery capability and to provide balance sheet strength whilst continuing to build a revenue generating pipeline. Further details on the use of proceeds are set out in paragraph 5 of this Appendix I.

The Placing, the Retail Offer, the Open Offer and the issue of the Convertible Loan Notes to Carbon Direct Capital, are each conditional upon, amongst other things, the passing of certain Resolutions in order to ensure that the Directors have the necessary authorities and powers to allot the New Ordinary Shares and issue the Convertible Loan Notes. A General Meeting is therefore being convened for the purpose of considering the Resolutions at 10.30 a.m. on 8 June 2023 at Magdalen Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford OX4 4GA. The Notice of General Meeting will be set out at the end of the Circular. The Placing, the Retail Offer and the Open Offer are also conditional on, inter alia, the Placing Agreement between the Company and the Joint Bookrunners becoming unconditional and not being terminated in accordance with its terms. The Placing, the Retail Offer and the Open Offer are not underwritten. The Placing, the Retail Offer and the Open Offer are not conditional on the issue of the Convertible Loan Notes. Subscription by Carbon Direct Capital for the Convertible Loan Notes is conditional on the Company having raised or having received legally binding commitments in respect of the Minimum Amount from the Fundraise. The Minimum Amount Condition has not currently been satisfied.

2.         Information on the Company

(a)        Overview of the Company

Velocys is an international sustainable fuels technology company, providing clients with one of the most sustainable routes to the economic production of drop-in SAF from a variety of waste materials. Velocys operates a capital light and scalable licencing model offering a technology solution for the development of synthetic sustainable fuels manufacturing via its proprietary patented micro-channel Fischer-Tropsch reactors and comprehensive biorefinery integrated technology package. The Company has offices in Oxford, UK as well as Houston, US and reactor manufacturing facilities in Ohio, US.

Velocys has a number of third party clients to whom it supplies its technology; in addition, Velocys is developing two full-scale biorefinery Reference Projects:

a)     the Bayou Fuels Project in Mississippi, US which will utilise woody waste to produce sustainable fuels

b)    and the Altalto Project in Immingham in the UK which will process municipal and commercial solid waste into sustainable fuels.

The Reference Projects are being developed to accelerate adoption of the Group's technology. Following the completion of third party construction capital project financing and commencement of the detailed engineering stage of these projects, the Reference Projects are expected to generate significant technology licensing revenue for the Group. Further details of each of the Reference projects is set out in sections e) and f) below. Velocys is building a strategic and financial partner network to attract new investors to the Reference Projects. As a consequence of new investors entering into the projects, Velocys expects its equity in the projects to be significantly diluted.

The Company's near-term ambitions are focused on creating sustainable shareholder value by growing the customer pipeline, progressing its biorefinery Reference Projects in the UK and US into FEED (Front End Engineering Design) delivery and revenue generation. Fees will start being generated as the Reference Projects enter into their FEED phase which will generate revenues through the execution of technology licenses and engineering services agreements. The Company is also focused on expansion of its commercial and business development functions, and engineering and reactor manufacturing to support the scale-up of its business.

The Company's aim is to become a leading provider of innovative SAF solutions to enable the decarbonisation of the aviation industry. The Company is moving towards achieving these ambitions whilst creating sustained shareholder value through a diverse client pipeline delivering significant one-off and recurring revenues.

The Group's technology has been commercially demonstrated through several customer projects since 2015 following the manufacturing of commercial reactors and catalysts: in 2017 a first commercial demonstration plant (the ENVIA plant, located in Oklahoma, US) using two of the Group's full-scale Fischer-Tropsch reactors and catalyst was completed and subsequently produced a fuel output that qualified under the Renewable Fuels Standard and was sold to commercial clients. Subsequently, construction of the NEDO I biomass demonstration project in Japan was successfully completed in late 2020 using the Group's proprietary Fischer-Tropsch technology. 3,000 litres of fuel from NEDO I were used in a Japan Airlines scheduled commercial flight in June 2021 becoming the first such flight using SAF derived from woodchips feedstock at any scale. Further details of these commercial demonstration plants are provided below.

In November 2021, the Group signed a 15-year fixed price offtake agreement with Southwest Airlines and a memorandum of understanding for a 10-year fixed price offtake with IAG for in aggregate 100 per cent. of the SAF to be produced and environmental credits generated from the Bayou Fuels Project. The Directors believe that these offtake agreements further validate the demand for the Group's technology and will significantly de-risk the Bayou Fuels Project which should enable construction capital financing of the project. Through the combination of biogenic feedstock, planned renewable power supply and carbon capture and storage (both currently in the pre-FEED phase), Velocys' micro-channel Fischer-Tropsch reactors and comprehensive biorefinery integrated technology package will enable the commercial-scale production of SAF at the Bayou Fuels Project with a deeply negative prospective Carbon Intensity of -375g CO₂e/MJ, which is expected to achieve a total of 1.3 million tonnes of avoided CO₂ per annum over the term of the contracts equivalent of 1.1 million return economy trips from San Francisco to London per year. Following the implementation of the highly beneficial Inflation Reduction Act in the US in August 2022, Velocys has appointed a leading global investment bank to raise FEED funding for the Bayou Project which is expected during the last quarter of 2023.

The Altalto Project is currently being developed in conjunction with British Airways who have an option over 50 per cent of the project. As announced on 12 December 2022, Altalto Limited has secured a grant from the UK Department for Transport (DfT) under the Advanced Fuels Fund up to a maximum of £27 million for the Altalto Project. The grant funding, which will be distributed over the 3-year grant period through to March 2025 and is conditional on private-sector matched funding over the course of the grant period, will enable Altalto to complete the critical FEED stage of the project. Altalto Limited has completed the work necessary to claim the first tranche (£7 million) of the grant up to 31 March 2023. In addition, as planned, the project has obtained the first tranche of private matched funding for the period from 1 April 2023 from its existing private sector participants (including a contribution of £1 million from Velocys). Velocys has appointed a leading global investment bank to assist in obtaining the required remaining matched funding from private sector investors to be in place in the last quarter of 2023 (pursuant to the terms of the grant funding).

In addition, the Group secured a separate grant of £2.5 million, also from the DfT's Advanced Fuels Fund, which offered a specific funding allocation for the development of e-fuels projects (those whose energy input is derived not from the carbon feedstock, which is carbon dioxide, but rather from renewable electricity via hydrogen). This grant was awarded to Velocys to assemble the technology package for an e-fuels project in the UK, the e-Alto power to liquids project, in collaboration with partners. 

In the first quarter of 2023, Velocys announced the execution of a master relationship agreement ("MRA") with Bechtel Limited ("Bechtel"), a leading worldwide provider of engineering, construction and project management services, as SAF project delivery partner to develop a centre of excellence model and provide project engineering and other technical services to Velocys' SAF project portfolio, thereby accelerating its commercialisation strategy and significantly de-risking project delivery by collaborating in development of a viable EPC execution model for the Company's Reference Projects. Initially the collaboration is focusing on Velocys' main Reference Projects - the Altalto Project and the Bayou Fuels Project - together with the recently announced e-Alto power-to-liquids project in the UK. The MRA also covers other third-party projects that may be introduced by either Bechtel or Velocys globally.

Under a separate continuing technical services agreement, Bechtel is providing certain other technical services to support the development of Velocys' SAF project portfolio. In particular, Bechtel has commenced work on delivery of the Altalto Project FEED phase advancing the Company towards revenue generation. 

The Group is focused on accelerating delivery of Velocys' technology and driving sustainable revenue opportunities.

Path to a dual listing

The Directors believe that a US Listing of the Company, in addition to its existing admission to trading on AIM, will further enhance the Company's reputation and increase global awareness of the Company's proprietary technology. The Company already has a significant presence in the US with its US office, manufacturing and catalysis facilities in Ohio, engineering office in Houston as well as the Bayou Fuels Project itself planned in Natchez Mississippi. A US Listing will provide access to a large pool of specialist investors and provide the potential for broader equity research coverage and increased liquidity.

Whilst it cannot be guaranteed, the Directors are confident that a US Listing can be achieved within 21 months from the issue of Convertible Loan Notes to Carbon Direct Capital. The Directors appreciate the significant sustained support they have received from UK and other investors to date during a key stage of the Company's growth and intend to maintain the Company's existing admission of its Ordinary Shares to trading on the AIM market of the London Stock Exchange for the foreseeable future alongside the intended US Listing.

 (b)       Technology overview

The Group's technology is an embodiment of the Fischer-Tropsch process which converts pure carbon monoxide and hydrogen synthesis gas (syngas) via a catalytic chemical reaction into hydrocarbons which are subsequently upgraded into fuels. The technology enables an economic conversion of a wide range of low or negative-cost, abundant sustainable feedstocks (including, but not limited to, woody biomass residue or municipal solid waste that would otherwise go to landfill or incineration) into high value sustainable fuels such as SAF. These fuels qualify for decarbonisation credits in both the United States (under the Renewable Fuels Standard) and in the United Kingdom (under the Renewable Transport Fuels Obligation). These fuels have significant air quality advantages and reduce the emission of particulates from aircraft by up to 90 per cent. and lifecycle greenhouse gas emissions reductions by up to 70 per cent., or over 150 per cent. when carbon capture and storage is incorporated within the biorefinery. 

The fuels are designed to be "drop-in", eliminating the need for engine modification, and to be blended with conventional fossil fuels, fully leveraging existing aircraft engines and logistics infrastructure. They are approved by the American Society for Testing and Materials for blending with Jet A-1 at up to 50 per cent., so no adaptation is required to airport infrastructure or aeroplane engines.

Although Fischer-Tropsch technology has been in existence for decades, Velocys has developed a highly reactive catalyst and a bespoke reactor to be used in an innovative way to manufacture sustainable fuels. Velocys' proprietary Fischer-Tropsch technology comprises microchannel Fischer-Tropsch reactor cores, containing a highly active Fischer-Tropsch catalyst made by Velocys' proprietary organic matrix combustion which are contained within a pressure containment vessel/reactor. Velocys' technology provides the unique combination of microchannel reactors and nanocatalyst technology that allows an 8-10 fold increase in the speed of chemical reactions compared with conventional Fischer-Tropsch technology, and therefore much smaller reactors for any given volume of throughput. Velocys' conversion pathway enables negative carbon intensity fuels via CO₂ sequestration of between 30 per cent. and 40 per cent. of the feedstock carbon used, with a corresponding air quality advantage via ultra-low Sulphur and a 2.5 particulate matter.

The technology is developed in-house by Velocys and is protected by a wide range of patents and trademarks across multiple key jurisdictions. The catalysts are manufactured at commercial scale by sub-contractors in the US under strict Velocys supervision. The reactor cores have previously been manufactured by subcontractors in the US using manufacturing equipment designed and owned by Velocys, however the Company intends to use some of the proceeds from the Fundraise to complete the capital investment in its Ohio reactor core manufacturing facility which will improve the automation and the capacity of this manufacturing by bringing final assembly, testing and quality control in-house while using qualified external contractors for standard components and sub-assemblies. The new facility will have capacity to produce 48 cores per annum, sufficient for 12 reactors (the typical requirement for a single biorefinery) which will be adequate to meet projected production capacity needs until 2028. The internal fit-out stage of the facility is now complete and is expected to commence process validation in the last quarter of 2023 with live production of reactor cores commencing in 2024.

(c)        Market overview

The market for SAF is growing rapidly as airlines and governments around the world are seeking to reduce the carbon footprint of air travel. Commercial aviation is responsible for approximately 13 per cent. of transportation greenhouse gas ("GHG") emissions. With the advent of government mandates requiring the use of SAF, the aviation industry seeks to reduce its GHG emissions significantly, decoupling airline growth from carbon growth. Purchasing fuel is the primary operating cost for airlines. SAF represents a significant global opportunity, with the value of decarbonisation far exceeding the value of the fuel where there is appropriate policy support for SAF. The International Air Transport Association ("IATA") has committed to net-zero carbon emissions by 2050, requiring 450 billion litres of SAF to meet these net-zero commitments. According to a report by the International Energy Agency, the demand for SAF is expected to grow from less than 0.1 per cent. of total aviation fuel consumption in 2020 to around 10 per cent. by 2030. This represents a significant opportunity for companies involved in the production, distribution and sale of SAF as supply is extremely limited - current annual production is approximately 100 million litres. Electric and hydrogen fuel solutions are not considered current or short-to-medium term viable solutions for long haul flights. SAF is a "drop-in" fuel that requires no modifications to engines or infrastructure and can still meet international specifications i.e., ASTM D7566 - a provision under D7566 which allows any fuel meeting the specifications to be reidentified as a conventional fuel. With this inclusion, any SAF can be seamlessly integrated into the fuel delivery infrastructure without the need for separate tracking or regulatory approval, so providing the most viable option to help achieve the net-zero commitments by 2050.

The Directors believe that the inevitable scale up in production of SAF and the growing number of government mandates will make the use of SAF widespread. The US has very competitive carbon incentives through its existing Federal Renewable Fuel Standard ("RFS") and the Low Carbon Fuels Standard ("LCFS") in California. The landmark Inflation Reduction Act of 2022 was passed by the US Congress in relation to key legislation tackling climate change in August 2022, allocating approximately $369 billion to reducing GHG emissions and incentivises expanded production and use of domestic clean energy. In the UK, the Government set out its Net Zero Strategy in 2021 for an economy-wide plan to achieve Net Zero by 2050. As part of this ambition, in order to decarbonise the aviation sector, in 2022 the UK Government's DfT set out its Jet Zero strategy setting out a framework for securing a more sustainable aviation industry with a target of at least 10 per cent. SAF blended into the jet fuel mix by 2030. To help deliver this, the Government has an ambition for a minimum of five commercial-scale SAF plants to be in construction in the UK by 2025. This is being supported by the £165 million Advanced Fuels Fund, from which Velocys is the largest recipient of grant funding. This builds significantly on the previous 2021 Green Fuels Green Skies grant initiative (of which Velocys was a recipient) which made available £15 million in grant awards and demonstrates the increasing support of the DfT.

On the 30 March the UK Government published its consultation paper, Pathway to net zero aviation: developing the UK sustainable aviation fuel mandate, which contains a number of proposals aimed at supporting and financing the development of the sustainable aviation fuel ("SAF") industry. The Government has confirmed its desire to establish the UK as a global leader in the development, production and use of SAF by creating secure and growing SAF demand, kickstarting a domestic SAF industry and working in partnership with industry and investors to build long term supply. The consultation comes amid growing support for decarbonisation and further supports the UK Government's ambition of reaching net zero by 2050 and its Jet Zero strategy. The proposed SAF mandate offers a guaranteed level of demand and creates a long-term requirement to supply SAF, provides incentives to SAF producers in the form of tradeable certificates and signals the vital role SAF will play in the future of UK aviation. The tradable certificates are intended to close the gap between the cost of jetfuel and the cost of SAF, with additional certificates awarded in proportion to avoided carbon dioxide emissions.

IATA's net-zero carbon emissions commitment, aligns with the Paris Agreement for global warming to not exceed 1.5°c. The EU has proposed to set SAF blending mandates via the ReFuelEU proposal published in July 2021. The Directors believe that these would likely be set at 2 per cent. by 2025, 5 per cent. by 2030 and 32 per cent. by 2040. The International Civil Aviation Organisation has introduced Carbon Offsetting and Reduction Scheme for International Aviation as a global mandate for decarbonisation of aviation and the Japanese Government has backed ventures launched to progress commercial scale SAF production.

The Directors believe that Velocys' conversion pathway offers a number of specific advantages. The Fischer-Tropsch Synthesised Paraffinic Kerosene route is the most established of the seven approved technical pathways under ASTM D7566, which allows the flexible use of large-volume, low-cost sustainable feedstocks (such as woody biomass residue and municipal solid waste) and generates clean burning, low carbon sustainable fuels. Velocys' standardised solution can ultimately also lead to a reduced cost of capital for clients when eligible for non-recourse project finance and can lead to sustainable local production and distribution of fuel, resulting in increased self-sufficiency and reduced reliance on fuel imports for the host country. Multiplate pilot demonstrations have been conducted in various global locations by 2015, including Brazil, Austria (in 2010) and Japan.

Expected demand for SAF in Europe and the US, based on the EU's latest proposals and current incentives in the US, is expected to reach 3.7 billion litres per year by 2025, equivalent to 2 per cent. of global jet fuel demand and the equivalent of the output from 28 reference plants. By 2030, demand for SAF is expected to rise to 10.3 billion litres per year, equivalent to 5 per cent. of global jet fuel supply and the equivalent of the output from 78 reference plants. By 2040, demand for SAF is expected to rise further to 77.6 billion litres per year, equivalent to 32 per cent. of global jet fuel supply and the equivalent of the output from 586 reference plants. 

Global SAF production was estimated to reach 0.3 to 0.45 billion litres in 2022, an increase on output of 0.1 billion litres in 2021. This has increased continually since 2019 (0.025 billion litres), with SAF output having climbed to 0.0625 billion litres in 2020. This mirrors an expected increase in global jet fuel demand, which is anticipated to grow from 457 billion litres in 2025 to a peak of 540 billion litres by 2045 (increasing by a rate of approximately 8-20 billion litres every 5 years), before dropping to 492 billion litres by 2050. Over the same period, the mandate for SAF is expected to increase from 4 billion litres in 2025 to 166 billion litres by 2050. Predictions for 2030 place Europe and the US as accounting for 40 per cent. combined of global jet fuel demand.

Velocys' ambition is to capture 5 to 7 per cent. of the long-term market share of the demand this will create for proven SAF technology. The Group has an active and growing pipeline of clients and projects. In 2025, the Directors expect that one of the Group's clients will be in construction and three of the Group's clients will be at the FEED phase. At this stage, the Group is aiming to have a total design capacity of 230 million litres per year, equivalent to 6 per cent. of the expected demand for SAF. By 2030, the Directors reasonably anticipate that 6 plants will have been completed by the Group's clients, delivering a capacity to meet 15 per cent. of the expected demand for SAF. By 2040, the Directors currently forecast that up to 45 plants will have been completed by the Group's clients with capacity to produce between 3.5 and 5 billion litres, equivalent to between 5 per cent. and 7 per cent. of the expected demand for SAF.

(d)        Business model

The Group has a hybrid, capital-light business model, focusing on delivering Fischer-Tropsch reactors and catalysts to global clients under site-licence agreements and providing engineering services over the course of the 25 year expected lifetime of the assets. Some of Velocys' clients require the Fischer-Tropsch Technology Island only ("FTI"). However, Velocys' core offering provides its clients with a full end-to-end solution for the conversion of solid sustainable feedstocks to SAF via its so called "Integrated Technology Package" ("ITP"). The Group's two biorefinery Reference Projects are designed to accelerate the end-to-end technology adoption as well as providing a source of future revenue to the Group. To date, the Group's technology is already commercially referenced through its contracts with a consortium including Toyo in Japan. The Group's FTI has been further demonstrated at commercial scale by the ENVIA plant in Oklahoma during 2017 and 2018, with integrated commercial operations and pilot trial upgrade for fuel and diesel product completed in 2019.

The Group's revenue from its ITP solution comprises a combination of upfront fees and recurring fees as follows:

-  

In 2021, Velocys recognised revenue of £8.3 million following the delivery of reactors and catalysts to prior years clients.

The Group is building a growing pipeline of international clients that are developing biorefineries and has sufficient production capacity to meet projected orders until 2028. This includes developing its existing relationships including with Toyo in Japan and pursuing new project opportunities. In 2021 Velocys signed a collaboration agreement with Toyo to start development of their commercial scale biomass-to-jet fuel project along with other renewable fuel opportunities. The Group is also undertaking a number of pre-feasibility studies with potential plant owners to ascertain the potential for projects to move into pre-detailed engineering and project development.

Further information on the Group's existing projects is provided below.

Revenue opportunity

Velocys offers a de-risked solution having undertaken multiple demonstrations in various global locations with the flexibility of various feedstocks from woodchips, residual waste, hydrogen and biomethane. With the ability to enable negative carbon intensity fuels via CO₂ sequestration of 30-40 per cent. of the feedstock carbon, which also has the advantage of improved air quality with ultra-low sulphur and 2.5 particulate matter, Velocys' standardised solution accelerates the path to non-recourse project financing and sustainable local production and distribution of synthetic fuels and provides a significant opportunity for growth in a sustainable fuel market with enormous unsatisfied demand particularly for SAF.

The business model is established to provide both upfront and recurring fees. The upfront fees consist of licence fee revenues which commence at the FEED stage of projects and are payable in instalments up to completion. Additional upfront fees are generated through reactor sales and initial catalyst down payments at start of project construction with final payments at completion along with engineering services payable throughout construction and commissioning of the plants and projects. The recurring revenues are derived from catalyst sales and service fees which recur every two years over the lifetime of the plant, in addition to royalties based on avoided carbon fuels production earned where Velocys has delivered early-stage project development as per the Reference Projects.

The Directors believe there is significant opportunity to expand its pipeline and contracts aided by increased reactor production capacity from its new reactor core manufacturing facility in Ohio. The below table provides illustrative examples of potential revenues generated from varying types of client projects:

¹10-year net cashflow - net cashflow to Velocys from FEED (Year 1) to year 6 (Year 10) of commercial production

²WACC 9.7 per cent.

Growth strategy

Velocys' ambition is to become a leading provider of advanced SAF solutions to enable the decarbonisation of the aviation industry by focusing on technology innovation. The Company's strategy to achieving this is centred around accelerating its two full scale biorefinery Reference Projects to generate revenues, accelerate technology adoption and define a blueprint for future clients.

By working with leading industry partners, the Company is advancing its current Reference Projects towards commercialisation, demonstrated by the Altalto Project entering its critical FEED phase supported by the UK Governments' Advanced Fuels Fund grant and the broad engineering collaboration with Bechtel. In the US, the Bayou Fuels Project is also moving towards the FEED phase with funding for project development capital expected to close during the last quarter of 2023 following the appointment of a leading global investment bank to source funds for the development phases of both Reference Projects.

The Directors believe the growth strategy for the Group is focused on strengthening its commercial development pipeline concentrating on revenue producing opportunities delivering valuable upfront services for clients and a wider reach on pipeline opportunities from increased enquiries and paid studies. In order to accelerate this capacity and pipeline, the new reactor core manufacturing facility in Ohio is targeting production in 2024 with an increased output capacity of 12 reactors per year. Additionally, the Company is looking to develop and grow its pipeline through significant investment in people, processes and systems. Velocys is looking to scale the organisation, by undertaking a selective recruitment process to gradually increase headcount from approximately 40 full time employees to approximately 100 full time employees over the next 12 to 18 months in line with increased contracted client demands, with a focus on engineering capacity in order to propel the Company towards sustainable revenue generation.

Velocys' growth strategy can be summarised as being to:

·      strengthen its business development function to grow its client pipeline;

·      invest in the scale-up of its reactor manufacturing capacity;

·      capitalise on strategic alliances with its technology partners to further enhance the Group's standardised integrated solution;

·      accelerate its collaborations with technology partners and to outsource standardised activities to remain capital light;

·      target geographical markets where the regulatory environment and/or pricing economies create the highest value opportunities for its clients; and

·      expand engineering and technical resources to support its clients' needs from feasibility stage to detailed engineering.

The Directors believe this growth strategy will enable the Group to have 6 clients with completed plants by 2030 with capacity to reach up to 15 per cent. of expected SAF demand with potential additional significant growth projected beyond this - the Directors currently forecast that up to 45 plants may be completed by the Group's clients by 2040 using Velocys' technology.

(e)        Bayou Fuels Project in Mississippi, US: reference project

Overview

In October 2017, the Group signed a site option agreement with Adams County in the State of Mississippi for a biorefinery facility to be located in Natchez, Mississippi and secured total site incentives of approximately $60 million. The Bayou Fuels Project is a planned cellulosic biofuels plant enabling the production of carbon negative fuel through the use of biogenic feedstock, renewable power, and carbon sequestration. The biorefinery, when it enters production planned for 2028, will convert 3,000 tons/day of woody biomass forestry residues into 36 million gallons/year (nameplate) of renewable transportation fuels, predominantly SAF, with a negative carbon intensity using renewable energy derived from sustainable biomass power.

In October 2022, the Group announced it had re-optimised its Bayou Fuels facility for maximum decarbonisation to a negative carbon intensity of -375g CO₂e/MJ (previously -144g CO₂e/MJ); abating the carbon emissions from the equivalent of 1.1 million return economy trips from San Francisco to London per year. This optimisation marks a significant improvement in the negative carbon intensity score of the plant with the potential to increase future revenue for the Bayou Fuels Project and enhance the attractiveness of the project for third party project funding.

Critical legislative developments in the US have taken place recently benefiting the Bayou Fuels Project, most significantly the US Inflation Reduction Act of 2022, signed into law on 16 August 2022, which allocates $369 billion to reducing greenhouse gas emissions and incentivises expanded production and use of domestic clean energy. A variety of SAF tax credits are an integral part of the Act, together with other incentives and mechanisms to accelerate the deployment of advanced fuel technologies generating non-fossil fuels with a significantly reduced carbon intensity. The biofuels that will be produced will adhere to both the US RFS and the LCFS and earn additional incentives through the associated Renewable Identification Number and LCFS credits. On 19 November 2021 the US House of Representatives passed a bill that provides a SAF Blenders Tax Credit, which is worth $1.75/gallon for the SAF produced from the Bayou Fuels Project. The US administration has recently announced additional policy incentives to accelerate the production of SAF, with up to $5 per gallon by way of SAF Producer Tax Credit indexed to carbon intensity, available from 2027, which would replace the SAF Blenders Tax Credit.

Following a competitive RFP process, the Group has appointed a leading global investment bank to assist in securing the necessary development capital from strategic partners for the project. The Group expects one or more clients to finance and own the construction of the Bayou Fuels Project with the terms of the financing determining Velocys' interests in the project post-financing. Potential scenarios include, inter alia, Velocys retaining a minority interest in the project or converting its interest into a "decarbonisation royalty" or receiving a development fee. Completion of this capital raise is expected in the last quarter of 2023.

Offtake agreements

Multi-year offtake contracts have been agreed, covering 100 per cent. of the SAF expected to be produced by the biorefinery plant, underwriting $3.1 billion in revenue and avoiding 18.7 million tons of CO₂. 

(i)  Offtake agreement with Southwest Airlines

On 10 November 2021, the Group entered into its first offtake agreement for the SAF to be produced by the Bayou Fuels Project with Southwest Airlines, America's largest domestic airline. The agreement covers the purchase by Southwest Airlines of an expected 219 million gallons of SAF at a fixed price and floor price for greenhouse gas credits, over a fifteen-year term from 2028, when the biorefinery is scheduled to begin commercial delivery of fuel. After blending, this is expected to produce approximately 575 million gallons of net zero SAF.

This offtake agreement covers two thirds of the project facility's planned production and de-risks up to $2 billion revenues over the life of the contract. Each gallon of SAF generated by the project is expected to generate tradable greenhouse gas credits for which Southwest Airlines guarantees a minimum price payable to the project (included in the fuel fixed price), de-risking a significant proportion of the revenue stream to the project. The project may additionally benefit from the value of greenhouse gas credits if sold above the minimum price underwritten by Southwest Airlines.

Southwest Airlines and Velocys have also, as part of the offtake agreement, agreed to a long-term strategic alliance for future US-based biorefineries in which Velocys may be involved with the right for Southwest Airlines to purchase significant volumes of SAF from such facilities.

The offtake agreement is subject to certain customary conditions precedent including completion of satisfactory financing for the project's front-end engineering and design phase and certain construction milestones, eligibility for greenhouse gas credits as well as the enactment of the proposed SAFs tax credit legislation.

(ii)  Offtake memorandum of understanding with IAG

On 10 November 2021, the Group entered into a non-binding memorandum of understanding for the offtake of SAF to be produced at the project with IAG. This covers the purchase by IAG's constituent airlines, which includes British Airways, Aer Lingus and Iberia amongst others, of an expected 73 million gallons of SAF, in aggregate, at a fixed price. After blending, this is expected to produce the equivalent of approximately 192 million gallons of net zero SAF during the term of the agreement, which will last for ten years from the expected commencement date of operation of the project in 2026. This represents one third of the facility's planned annual output and complements the binding offtake agreement for the remaining two thirds annual output entered into on the same date with Southwest Airlines as described above.

The intention of the parties is to convert the memorandum of understanding, which includes all material terms for the offtake, into a binding agreement as the project progresses. The memorandum of understanding also includes an option for IAG to invest in the Bayou Fuels Project development phases.

The fixed price fuel purchase agreement includes a price support mechanism by IAG for the greenhouse gas credits associated with the SAF production. As a result, the agreement is expected to generate revenues of over $800 million to the project and achieve an estimated total of 2.2 million tonnes of avoided CO₂ over the term of the offtake.

Future milestones

The Company is intending to raise development capital for the Bayou Fuels Project closing in the third quarter of 2023 to advance from FEED to FID stage. A leading global investment bank has been appointed as financial advisor to the project. Initial engineering for the project has commenced, with detailed engineering expected to commence in 2024. Design capacity for the site is expected to be 108,000 tonnes per year of SAF generating over 1.3 million tonnes per year of CO₂ avoided with ultra-low negative carbon intensity, with the aim to enter production in 2028 and increase this figure to 1.8 million tonnes per year of avoided CO₂. Levee construction is anticipated to be finalised in the last quarter of 2023, a critical milestone for insurance and de-risking of the site. Signature of the final commercial agreements for the project, FID and financial close is expected in 2025, following which plant construction is expected to occur during 2025 and 2026. Construction is targeted to be completed by 2027 followed by plant commissioning and start up with full scale commercial operation targeted to commence in 2028.

 (f)        Altalto Project in Immingham, UK: reference project

Overview

The Group's Altalto Project, which is administered through a joint development agreement between the Company and British Airways, will take household and commercial waste which, after recyclates have been removed, would be destined for landfill or incineration, and instead converts that waste into clean-burning SAF and naphtha.

The Group has completed feasibility work in relation to site engineering, geotechnical survey and integration of carbon sequestration of biogenic CO₂ in preparation for the connection of the Altalto plant, when built, into a new Carbon Capture and Storage cluster, which is being developed by a consortium.

In March 2022, Altalto Immingham Ltd (a subsidiary of the Group) sold its 100 per cent. interest in Rula Developments (Immingham) Limited ("RDIL"), which owns the site for the Altalto Project, to Foresight Group LLP for £9.75 million, with a call option for Altalto to repurchase RDIL within three years. Foresight has a proven track record and history of investing in energy transition infrastructure and also has an option to invest up to £100 million in the future project construction phase. Following the sale, the Project has retained the right to access the land for maintenance and pre-development activities associated with its existing planning permission.

As announced on 12 December 2022, the Group secured a grant from the DfT under the Advanced Fuels Fund up to a maximum of £27 million for the Altalto Project. The Advanced Fuels Fund prioritises first-of-a-kind commercial scale SAF plants that require additional support to become ready for investment and construction. The fund also aims to leverage private investment, both by supporting projects to reach an "investor ready" status and by prioritising projects that have secured matched funding. The grant funding, which will be distributed over the grant period through to March 2025 will support Altalto to deliver the FEED stage of the project, which will incorporate the integrated technology packages of the licensors (including Velocys) and develop the basis for the Engineering, Procurement and Construction ("EPC") contract. The Group has obtained letters of intent from a number of existing and new potential partners for the private-sector matched funding requirement with the first tranche of funding due to be in place during the first half of 2023.

Velocys has previously received grants for the Altalto project of £1.7 million from the DfT's Green Fuels, Green Skies competition and a series of grants totalling £934,000 from the Future Fuels for Flight and Freight competition, the predecessor to Green Fuels, Green Skies.

Further to legislative developments in the US, the UK legislation has also progressed, with the UK Government's Net Zero Strategy including developing a SAF mandate to enable delivery of 10 per cent. SAF by 2030. The UK DfT also announced its Jet Zero Strategy in July 2022, setting out the Government's approach for achieving net zero aviation by 2050. This includes an ambition for a minimum of five commercial-scale SAF plants to be under construction in the UK by 2025 which is being supported by the £165 million Advanced Fuels Fund. Nevertheless, the continued lack of finalised UK policy support also poses challenges for the Altalto Project. The Company looks forward to the conclusion of the UK Government's consultation process and finalised plans for the policy support necessary to kick-start the UK based SAF industry.

The Group has agreed with British Airways to further extend the terms of both the Altalto Project's joint development agreement and the option agreement which allows British Airways to acquire 50 per cent. of Altalto Limited by one year to 31 March 2024

Velocys' cash contribution to the Altalto Project over two years from April 2023 is not expected to exceed £8 million, with Velocys intending to achieve a net zero contribution.

Future milestones

A leading global investment bank has been appointed raise the Altalto Project matched funding (alongside the DfT grant). Completion of this development capital raise is expected during the last quarter of 2023. The FEED phase is underway, with construction expected to commence in the second half of 2025, following which full scale commercial operation is anticipated in the second half of 2028. Current expectations for the site include a design capacity of 60,000 tonnes per year, with 350,000 tonnes per year of CO₂ avoided via the carbon capture system. The Directors believe that fuel produced from the Altalto Project could be worth over £3 per litre if rewarded in proportion to CO₂ reduction, plus any additional price support that may be provided.

(g)        Other revenue generating clients and pipeline

The Company continues to provide services and support to Toyo Engineering Corporation in Japan under the Collaboration Agreement signed in late 2021 as progress continues on the NEDO projects to proceed towards the FEED phase in 2024. In addition, the business development pipeline continues to grow, with a number of feasibility studies underway with both biorefinery and advanced power-to-liquid developers, as well as a significant increase in enquiries for potential projects. Velocys expects to move forward with a number of new clients globally through 2023.

Separate to the Altalto Immingham Project grant, the Group has secured a grant of £2.5 million, also from the DfT's Advanced Fuels Fund for the development of an e-fuels projects (those where energy input is derived not from carbon feedstock, which is carbon dioxide, but rather from renewable electricity via hydrogen). This e-fuels grant has been awarded to Velocys to assemble the technology package for an e-fuels project in the UK, in collaboration with a number of new and existing partners.

3.         Current Trading

Whilst Velocys continues to progress its Reference Projects with its partners and develop its longer-term pipeline, the Company is focused on near term revenue generation and delivering sustainable shareholder value. Velocys has made substantial progress over the last year on both projects and has achieved a number of key milestones and objectives which place the Company in a strong position to progress its Reference Projects through to key valuation inflection points and build its commercial pipeline.

The Company announced its preliminary unaudited results for the year ended 31 December 2022 today 18 May 2023. As of 31 December 2022, Velocys had a cash balance of £13.4 million (2021: £25.5 million). Preliminary unaudited revenues are approximately £0.2 million (2021: £8.3 million) and a net loss of £13.2 million (2021: £8.4 million). As of 30 April 2023, the Company had a cash balance of £8.1 million (including £0.6 million of restricted cash).

Annual revenues are expected to remain uneven in the short-term due to the growing but concentrated number of SAF projects in development whilst the market becomes more established. Revenue generated in 2021 was in respect of engineering feasibility services provided during the year whereas the 2021 revenue was mainly the conclusion of a contract with our first major commercial client, which commenced in 2017, for the supply of reactors and catalyst, and associated licensing fees to operate the technology. The Company satisfied the performance obligations within the contract in June 2021 following expiry of all contractual obligations and therefore recognised the revenue and associated cost of goods in 2021.

4.         IP Portfolio

Velocys has an extensive and actively managed intellectual property portfolio of over 200 granted patents, 90 pending patents and various trademarks. Substantive IP is important for SAF as a relatively new technology and the development of new SAF feedstocks, production processes and applications requires significant R&D investment. It is essential for creating a competitive market for SAF and encourages continued innovation and provides a measure of security and stability for investment. It also underpins Velocys' licensing agreements, joint ventures and other commercial arrangements that helps to expand the market for SAF and increase its adoption.

5.         Use of Proceeds

The Group is focused on accelerating delivery of Velocys' technology and driving revenue opportunities through the economic production of SAF with the mission of facilitating decarbonisation of the aviation industry.

The Directors intend to use the net proceeds from the Placing, the Retail Offer and the Open Offer as follows:

o  £5 million - Organisation costs including project delivery and business development;

o  £1 million - engineering scale-up with investment in engineering resource; and

o  Balance - working capital requirements to invest in achieving supply chain resilience and to cover timeline of grant receipts.

In the event of the Minimum Amount being raised, the net proceeds of the issuance of the Convertible Loan Notes to Carbon Direct Capital and the issuance of further Convertible Loan Notes and/or Ordinary Shares to investors other than Carbon Direct Capital will be used primarily for:

o  £12 million - scaling-up of the organisation and corporate costs including increasing labour from approximately 40 full time employees to approximately 100 full time employees gradually over the next 12 to 18 months in line with client and project demand in order to accelerate the capability of the Company to deliver its technology to its clients at scale;

o  £7 million - completion of capital investment in the Ohio reactor core manufacturing facility including production start-up and catalysis upgrades;

o  £3 million - funding for US Listing costs or interest payments due on the Convertible Loan Notes in the event no US Listing occurs during the 21-month period from issue of the Convertible Loan Notes;

o  £2 million - supporting performance guarantees for the Company's proprietary Fischer-Tropsch technology to be delivered to client projects;

o  £1 million - working capital requirements, build-up of reactor inventory at the Ohio manufacturing facility and to manage timing of payments and grant receipts; and

o  additional funds raised up to the Maximum Amount, will be used to drive further commercialisation and balance sheet strength ahead of a potential US listing.

6.         Principal terms of the Convertible Loan Notes.

In addition to the Placing, the Retail Offer and the Open Offer, the Company proposes raising a minimum of $15 million (approximately £12 million), before expenses, by way of the proposed, conditional, non-pre-emptive issue to Carbon Direct Capital of Convertible Loan Notes, convertible into Ordinary Shares at the Issue Price. The Company intends to issue further Convertible Loan Notes and/or new Ordinary Shares to investors other than Carbon Direct Capital. The terms of the Convertible Loan Notes are governed by the Convertible Loan Note Instrument.

Pursuant to the Commitment Letter, the issue of Convertible Loan Notes to Carbon Direct Capital is conditional, inter-alia, upon the passing of the Resolutions at the General Meeting. If this condition is not satisfied, the Convertible Loan Notes will not be issued to Carbon Direct Capital. In addition to (i) the passing of the Resolutions, the issue of the Convertible Loan Notes is also conditional upon (ii) the Company raising or having received legally binding commitments to raise at least $40 million (approximately £32 million) less the amount subscribed for by Carbon Direct Capital in aggregate, before expenses, through the Fundraise from other investors other than Carbon Direct Capital (the "Minimum Amount") by no later than 30 September 2023 (the "CLN Long Stop Date") and (iii) there being no material breach of certain of the representations and warranties of the Company as given in the Commitment Letter between the date of the Commitment Letter and the date of issuance of the Convertible Loan Notes to Carbon Direct Capital. The Company and Carbon Direct Capital may agree to extend the CLN Long Stop Date to no later than 31 December 2023.

The key terms of the Convertible Loan Note Instrument are:

·      each of the CLN Investors has the right to convert all or part of its Convertible Loan Notes into fully-paid Ordinary Shares at any time;

·      unless earlier converted into Ordinary Shares or redeemed, the Convertible Loan Notes shall be automatically converted into fully-paid Ordinary Shares conditional on, and immediately prior to, the commencement of trading on a US Listing;

·      unless already converted into Ordinary Shares or redeemed, the outstanding amounts under the Convertible Loan Notes (being the principal amounts of the Convertible Loan Notes plus accrued interest) shall be redeemed in cash by the Company or converted in full or in part at the election of the relevant CLN Investor on the date that falls 36 months following their issue (the "Final Maturity Date");

·      if any of the Company or certain members of the Group suffers an insolvency event, if a change of control transaction has occurred, or if the admission to trading on AIM of the Ordinary Shares is cancelled (save in connection with a US Listing or other listing of the Company's securities on an investment exchange), the outstanding Convertible Loan Notes shall, at the election of the relevant CLN Investor, be redeemed in cash by the Company at 1.5 times the outstanding amount or be converted into Ordinary Shares;

·      if a lender to any member of the Group takes any step to enforce any security granted to that lender by any member of the Group as a result of an event of default by any member of the Group where the indebtedness is at least £100,000 in the aggregate, the relevant CLN Investor shall have the right to elect for its outstanding Convertible Loan Notes to be redeemed in cash by the Company;

·      notwithstanding any other provision in the Convertible Loan Note Instrument, in the event that a conversion into Ordinary Shares would result in a CLN Investor (together with any persons acting in concert with it) holding 30 per cent. or more of the voting rights of the Company, the relevant CLN Investor shall be entitled to convert such number of Convertible Loan Notes as would cause it (together with any person acting in concert with it) to hold up to 29.99 per cent. of the voting rights of the Company but shall not in any circumstances be obliged to make a conversion in respect of those Convertible Loan Notes that would result in it (together with any person acting in concert with it) holding 30 per cent. or more of the voting rights of the Company (the "Excess Notes"), and if not converted at the election of the relevant CLN Investor, the Excess Notes will remain outstanding until the date on which the Company obtains a Rule 9 waiver from the Panel on Takeovers and Mergers, following which the Excess Notes shall be converted or redeemed in cash by the Company if agreed;

·      on conversion of the Convertible Loan Notes to Ordinary Shares, such number of fully-paid Ordinary Shares shall be issued to the CLN Investors that equals the outstanding principal amount of the notes plus any applicable interest (converted into Sterling at the time of conversion) at a price of 2.5 pence per Ordinary Share or, if lower, the lowest price per Ordinary Share at which the Company issues Ordinary Shares to a Shareholder or investor in connection with an equity fundraising by way of the issue of new Ordinary Shares in the Company, or the conversion or exercise price for any further issue of convertible loan notes or issues of warrants, if any, which is completed after the date of the issuance of the Convertible Loan Notes but prior to the date of conversion of the Convertible Loan Notes;

·      the Convertible Loan Notes will not bear interest if the US Listing is completed within 21 months of the date of issuance of the Convertible Loan Notes and the Convertible Loan Notes are converted into fully-paid Ordinary Shares on such US Listing (to the extent not already redeemed or converted). The Convertible Loan Notes bear interest at an annualised interest rate of 12.5 per cent. from the date of issuance of the Convertible Loan Notes until the Final Maturity Date or earlier conversion or redemption which shall accrue in varying monthly coupons after the period of 21 months from the date of issue of the Convertible Loan Notes;

·      while any Convertible Loan Notes remain outstanding, the Company shall not pay any dividends or make any repurchases of its Ordinary Shares or other class of shares; and

·      the Convertible Loan Notes are not transferable, save to affiliates.

The maximum number of Ordinary Shares that may be issued on conversion of the Convertible Loan Notes that are proposed to be issued to Carbon Direct Capital and to other investors (assuming the balance of the Maximum Amount, less funds raised pursuant to the Placing,, is subscribed for in Convertible Loan Notes and further assuming that all Convertible Loan Notes are converted on the Final Maturity Date together with all accrued interest at a conversion price of 2.5 pence and on the basis of a currency exchange rate of GBP/USD 1.2487, being the Bloomberg rate on 17 May 2023 (the last practicable date prior to the publication of this document) is 1,662,351,597 Ordinary Shares. The Ordinary Shares issued on a conversion of the Convertible Loan Notes will, when issued, rank pari passu in all respects with the other Ordinary Shares then in issue, including all rights to all dividends and other distributions declared, made or paid thereafter.

The Convertible Loan Notes will not be admitted to trading on AIM or any other investment exchange.

The Commitment Letter contains warranties from the Company in favour of Carbon Direct Capital in relation to (amongst other things) the Company and its business and Carbon Direct Capital's commitment to acquire Convertible Loan Notes is conditional on there having been no material breach of certain of the warranties by the Company prior to issuance of the Convertible Loan Notes to Carbon Direct Capital.

7.         Principal terms of the Placing

The Company is conducting a conditional, non-pre-emptive placing and retail offer to raise approximately £6 million at the Issue Price. The Placing Shares a will be placed by Panmure Gordon and Shore Capital as agents for the Company and pursuant to the Placing Agreement, with institutional and other professional investors.

The Issue Price represents a discount of 26.9 per cent. to the closing mid-market price of the Ordinary Shares as at 17 May 2023 of 3.42 pence per Ordinary Share. The Placing Shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the other Ordinary Shares then in issue, including all rights to all dividends and other distributions declared, made or paid following Admission.

The Placing is conditional upon (amongst other things):

(a)        the passing of the Resolutions relating to the Placing, the Retail Offer and the Open Offer at the General Meeting;

(b)        the Company allotting, subject only to Admission, the Placing Shares in accordance with the Placing Agreement;

(c)        none of the warranties given by the Company in the Placing Agreement being untrue, inaccurate or misleading to an extent which would be material as at the date of the Placing Agreement or at any time between the date of the Placing Agreement and Admission;

(d)        Admission having occurred by no later than 8.00 a.m. on 9 June 2023 or such later date as the Company and the Joint Bookrunners may agree, but in any event not later than the Placing Long Stop Date; and

(e)        the Company having complied with its obligations under the Placing Agreement.

The Placing Agreement contains warranties from the Company in favour of Panmure Gordon and Shore Capital in relation to (amongst other things) the Company and its business. In addition, the Company has agreed to indemnify Panmure Gordon and Shore Capital in relation to certain liabilities it may incur in undertaking the Placing. Panmure Gordon and Shore Capital have the right to terminate the Placing Agreement in certain circumstances prior to Admission, in particular, it may terminate in the event that there has been a material breach of any of the warranties or for force majeure.

Application will be made for the Placing Shares to be admitted to trading on AIM. It is expected that trading in Placing Shares will commence at 8.00 a.m. on or around 9 June 2023.

It is expected that certain Directors and senior management in the Company will subscribe for New Ordinary Shares through the Placing for an aggregate amount of approximately £75,000. Further details will be announced as appropriate in due course. 

8.         Principal terms of the Open Offer

The Company considers it important that, where reasonably practicable, Eligible Shareholders have an opportunity to participate in its equity fundraisings. Accordingly, the Company intends to raise up to approximately £2 million (before expenses) by way of the Open Offer.

The Open Offer has been structured such that the Maximum Amount that can be raised by the Company under the Retail Offer and the Open Offer will not exceed the sterling equivalent of €8 million. The limit of approximately £2 million for the Retail Offer and the Open Offer has been set to allow existing Eligible Shareholders to participate in the Fundraise, taking into account the dilution of Eligible Shareholders not able to participate in respect of the Placing and the capital needs of the Company. The maximum aggregate limit of the Retail Offer and the Open Offer also ensures that the Company is not required to produce an approved prospectus pursuant to section 85 of FSMA. The issue of a prospectus would considerably increase the costs of the Fundraise and it would take much longer to complete, as any such prospectus would require the prior approval of the FCA.

On and subject to the terms and conditions of the Open Offer, the Company invites Eligible Shareholders, being only those Shareholders who are resident in the United Kingdom and who are not Sanctioned Shareholders on the Ex-Entitlement Date, to apply for their Basic Entitlement of Open Offer Shares at the Issue Price. Each Eligible Shareholder's Basic Entitlement has been calculated on the basis of 1 Open Offer Share for every 18 Existing Ordinary Shares held at the Record Date.

Eligible Shareholders are also invited to apply for additional Open Offer Shares in accordance with the Excess Entitlement. Any Open Offer Shares not issued to an Eligible Shareholder pursuant to their Basic Entitlement will be apportioned between those Eligible Shareholders who have applied for the Excess Entitlement at the sole discretion of the Board, provided that no Eligible Shareholder shall be required to subscribe for more Open Offer Shares than they have specified on the Application Form or through CREST.

The Open Offer is conditional upon (amongst other things):

(a)     the passing of the Resolutions relating to the Placing, the Retail Offer and the Open Offer at the General Meeting;

(b)    the Placing Agreement becoming unconditional and the Placing Agreement not having been terminated in accordance with its terms; and

(c)     Admission occurring on or before 9 June 2023 (or such later date as Panmure Gordon, Shore Capital and the Company may agree, not being later than 23 June 2023).

The Open Offer Shares have not been and are not intended to be registered or qualified for sale in any jurisdiction other than the United Kingdom. Accordingly, unless otherwise determined by the Company and effected by the Company in a lawful manner, the Application Form will not be sent to existing Shareholders with registered addresses in any jurisdiction other than the United Kingdom since to do so would require compliance with the relevant securities laws of that jurisdiction. The Application Form will not be sent to any Sanctioned Shareholders. Applications from any such person will be deemed to be invalid. If an Application Form is received by any Sanctioned Shareholder or any Shareholder whose registered address is elsewhere but who is in fact a resident or domiciled in a territory other than the United Kingdom, it should not seek to take up its allocation.

The Circular contains the full terms and conditions of the Open Offer.

9.         Recommendation

The Directors consider that the Fundraise and the Resolutions are in the best interests of the Company and its Shareholders as a whole. The Company is reliant on the net proceeds of the Placing, the Retail Offer and the Open Offer to meet its ongoing liquidity requirements and to continue to implement its strategy. Funds raised through the Placing, the Retail Offer and the Open Offer will be used primarily to provide growth capital in preparation for significant scale-up and working capital through expected key valuation inflection points. The Company intends to use any further funds raised in connection with the Fundraise (other than through the Placing, the Retail Offer and the Open Offer) for the purposes of driving the Company's technology delivery capability and to provide balance sheet strength whilst continuing to build a revenue generating pipeline. If the Resolutions are not passed by Shareholders, the Fundraise will not proceed. In these circumstances, the Directors will need to reconsider the Company's strategy and the Company may need to seek alternative funding, which may not be available on terms which are acceptable to the Company or at all. Accordingly, the Directors unanimously recommend that Shareholders vote in favour of the Resolutions, as they intend to do in respect of their own legal and/or beneficial shareholdings, amounting, in aggregate, to 4,654,896 Ordinary Shares (representing approximately 0.3 per cent. of the Ordinary Shares in the issue as at the date of this announcement).

APPENDIX II

TERMS AND CONDITIONS OF THE PLACING

INTRODUCTION

IMPORTANT INFORMATION FOR PLACEES ONLY REGARDING THE PLACING.

THIS ANNOUNCEMENT, INCLUDING THIS APPENDIX, AND THE INFORMATION IN IT, IS RESTRICTED, AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN ("THE EXCLUDED TERRITORIES") OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

IMPORTANT INFORMATION ON THE PLACING FOR INVITED PLACEES ONLY.

THE PLACING SHARES THAT ARE THE SUBJECT OF THE PLACING ARE NOT BEING OFFERED OR SOLD TO ANY PERSON IN THE EUROPEAN UNION OR THE UK, OTHER THAN TO QUALIFIED INVESTORS, WHICH INCLUDES LEGAL ENTITIES WHICH ARE REGULATED BY THE FCA OR ENTITIES WHICH ARE NOT SO REGULATED WHOSE CORPORATE PURPOSE IS SOLELY TO INVEST IN SECURITIES.

MEMBERS OF THE PUBLIC IN THE UK OR ELSEWHERE ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT (INCLUDING THIS APPENDIX) AND THE TERMS AND CONDITIONS SET OUT HEREIN ARE FOR INFORMATION PURPOSES ONLY AND ARE DIRECTED ONLY AT: (A) PERSONS IN A MEMBER STATE OF THE EUROPEAN ECONOMIC AREA WHO ARE QUALIFIED INVESTORS (WITHIN THE MEANING OF THE PROSPECTUS REGULATION (EU) 2017/1129) ("PROSPECTUS REGULATION"); (B) PERSONS IN THE UNITED KINGDOM WHO ARE QUALIFIED INVESTORS WITHIN THE MEANING OF THE UK VERSION OF THE PROSPECTUS REGULATION WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMENDED AND SUPPLEMENTED (INCLUDING BY THE UK PROSPECTUS AMENDMENT REGULATIONS 2019 AND THE FINANCIAL SERVICES AND MARKETS ACT 2000 (PROSPECTUS) REGULATIONS 2019) WHO ALSO (I) HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005 ("ORDER") (INVESTMENT PROFESSIONALS) OR (II) FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER (HIGH NET WORTH COMPANIES, UNINCORPORATED ASSOCIATIONS ETC.) AND (C) THOSE PERSONS TO WHOM IT MAY OTHERWISE BE LAWFULLY COMMUNICATED (EACH SUCH PERSONS REFERRED TO ABOVE BEING A "RELEVANT PERSON"). THIS ANNOUNCEMENT (INCLUDING THIS APPENDIX) AND THE TERMS AND CONDITIONS SET OUT HEREIN MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT (INCLUDING THIS APPENDIX) AND THE TERMS AND CONDITIONS SET OUT HEREIN RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS.

THIS APPENDIX, AND THE ANNOUNCEMENT OF WHICH IT FORMS PART, IS FOR INFORMATION PURPOSES ONLY IS NOT INTENDED TO FORM THE BASIS OF ANY INVESTMENT ACTIVITY OR DECISION, AND SHOULD NOT BE CONSIDERED AS A RECOMMENDATION BY THE COMPANY THAT ANY RECIPIENT SHOULD ACQUIRE ANY INTEREST IN THE SHARE CAPITAL OR ANY OTHER INTEREST IN THE COMPANY. IT DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY. IF YOU ARE IN ANY DOUBT AS TO WHETHER YOU ARE A RELEVANT PERSON YOU SHOULD CONSULT A PROFESSIONAL ADVISER FOR ADVICE.

THIS ANNOUNCEMENT IS NOT AN OFFER FOR SALE OR SUBSCRIPTION IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION. THIS ANNOUNCEMENT IS NOT AN OFFER OF OR SOLICITATION TO PURCHASE OR SUBSCRIBE FOR SECURITIES IN THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES EXCEPT PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THE PLACING SHARES ARE BEING OFFERED AND SOLD ONLY (I) OUTSIDE OF THE UNITED STATES IN "OFFSHORE TRANSACTIONS" AS DEFINED IN AND IN ACCORDANCE WITH REGULATION S UNDER THE SECURITIES ACT ("REGULATION S") AND OTHERWISE IN ACCORDANCE WITH APPLICABLE LAWS AND; (II) IN THE UNITED STATES TO A LIMITED NUMBER OF "QUALIFIED INSTITUTIONAL BUYERS" ("QIB") AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THERE WILL BE NO PUBLIC OFFER OF THE SECURITIES MENTIONED HEREIN IN THE UNITED STATES.

EACH PLACEE SHOULD CONSULT WITH ITS OWN ADVISERS AS TO LEGAL, TAX, BUSINESS AND RELATED ASPECTS OF AN INVESTMENT IN PLACING SHARES. THE PRICE OF THE PLACING SHARES IN THE COMPANY AND THE INCOME FROM THEM (IF ANY) MAY GO DOWN AS WELL AS UP AND INVESTORS MAY NOT GET BACK THE FULL AMOUNT INVESTED ON DISPOSAL OF THE PLACING SHARES.

Placees will be deemed to have read and understood this announcement and these terms and conditions in their entirety and to be making such offer on the terms and conditions and to be providing the representations, warranties, acknowledgements, and undertakings contained in this Appendix. In particular, each such Placee represents warrants and acknowledges that:

1.  it is a Relevant Person and undertakes that it will acquire, hold, manage or dispose of any Placing Shares that are allocated to it for the purposes of its business;

2.  in the case of any Placing Shares acquired by it as a financial intermediary, as that term is used in Article 5(1) of the Prospectus Regulation, (i) the Placing Shares acquired by it have not been acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in any Member State of the EEA or the UK other than Qualified Investors or in circumstances in which the prior consent of the Joint Bookrunners has been given to the offer or resale; or (ii) where Placing Shares have been acquired by it on behalf of persons in any Member State of the EEA or the UK other than Qualified Investors, the offer of those Placing Shares to it is not treated under the Prospectus Regulation as having been made to such persons; and/or

3.  except as otherwise permitted by the Company and subject to any available exemptions from applicable securities laws, it (and any person on whose account it is acting) is (a) located outside the United States and is acquiring the Placing Shares in an "offshore transaction" as defined in, and in accordance with, Regulation S ; or (b) if within the United States, is a QIB.

The Company and the Joint Bookrunners will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements. Neither of the Joint Bookrunners makes any representation to any Placee regarding an investment in the Placing Shares referred to in this announcement (including this Appendix).

This announcement (including this Appendix) does not constitute an offer and may not be used in connection with an offer, to sell or issue or the solicitation of an offer to buy or subscribe for Placing Shares in any jurisdiction in which such offer or solicitation is or may be unlawful. This announcement (including this Appendix) and the information contained herein is not for publication or distribution, directly or indirectly, to persons in the United States, the Excluded Territories or in any jurisdiction in which such publication or distribution is unlawful. Persons who come into possession of this announcement are required by the Company to inform themselves about and to observe any restrictions of transfer of this announcement. No public offer of securities of the Company under the Placing is being made in the United Kingdom, the EEA, the United States, Hong Kong or any Excluded Territory.

In particular, the Placing Shares referred to in this announcement have not been and will not be registered under the Securities Act or under any laws of, or with any securities regulatory authority of, any state or other jurisdiction of the United States, and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction in the United States. The Placing Shares are only being offered and sold only (i) outside the United States in offshore transactions as defined in and in accordance with Regulation S; and (ii) in the United States to a limited number of QIBs pursuant to an exemption from the registration requirements of the Securities Act.

The relevant clearances have not been, nor will they be, obtained from the securities commission of any province or territory of Canada; no prospectus has been lodged with or registered by the Australian Securities and Investments Commission or the Japanese Ministry of Finance; and the Placing Shares have not been, nor will they be, registered under or offered in compliance with the securities laws of any state, province or territory of any of the Excluded Territories. Accordingly, the Placing Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into the Excluded Territories or any other jurisdiction where it would be unlawful to do so.

Persons (including, without limitation, nominees and trustees) who have a contractual or other legal obligation to forward a copy of this Appendix or the announcement of which it forms part should seek appropriate advice before taking any action.

TIMETABLE FOR THE PLACING

Following the release of this announcement, the Joint Bookrunners will today commence the Bookbuild to determine demand for participation in the Placing by Placees. This Appendix gives details of the terms and conditions of, and the mechanics of participation in, the Placing. No commissions will be paid to Placees or by Placees in respect of any Placing Shares.

The Joint Bookrunners and the Company shall be entitled to effect the Placing by such alternative method to the Bookbuild as they may, in their sole discretion, determine.

The number of the Placing Shares will be established in the Bookbuild and announced by the Company through a Regulatory Information Service following the completion of the Bookbuild and the entry into the Placing Shares Agreement by the Company and the Joint Bookrunners.

Various dates referred to in this announcement are stated on the basis of the expected timetable for the Placing. It is possible that some of these dates may be changed. The Placing Shares will be allotted on 8 June 2023, conditional upon Admission becoming effective on 9 June 2023.

DETAILS OF THE PLACING

The Joint Bookrunners have entered into the Placing Agreement with the Company under which the Joint Bookrunners have (severally, and not jointly or jointly and severally), on the terms and subject to the conditions set out therein, undertaken to use their respective reasonable endeavours to procure, as agents for the Company, subscribers for the Placing Shares at the Issue Price.

The Placing Agreement contains customary warranties and indemnities given by the Company to the Joint Bookrunners as to matters relating to the Company and its business in respect of liabilities arising out of, or in connection with, the Placing.

The Bookbuild is expected to close at 11.00 a.m. GMT tomorrow, 19 May 2023, but may be closed earlier, or later, at the discretion of the Joint Bookrunners. The Joint Bookrunners may, in agreement with the Company, accept bids received after the Bookbuild has closed.

The Joint Bookrunners (after consultation with the Company and on the basis of allocations agreed between the Company and the Joint Bookrunners) reserve the right to scale back the number of Placing Shares to be subscribed by any Placee in the event of applications in excess of the target amount under the Placing. The Company and the Joint Bookrunners also reserve the right not to accept offers to subscribe for Placing Shares or to accept such offer in part rather than in whole. The Joint Bookrunners shall be entitled to effect the Placing by such method as they shall in their sole discretion determine. To the fullest extent permissible by law, neither of the Joint Bookrunners nor any holding company of a Joint Bookrunner nor any subsidiary branch or affiliate of a Joint Bookrunner (each an affiliate) nor any person acting on behalf of any of the foregoing shall have any liability to the Placees (or to any other person whether acting on behalf of a Placee or otherwise). In particular, neither of the Joint Bookrunners, nor any affiliate thereof nor any person acting on their respective behalves shall have any liability to Placees in respect of their conduct of the Bookbuild or the Placing.

Each Placee's obligations will be owed to the Company and to the Joint Bookrunners. Following the confirmation referred to below in the paragraph entitled "Participation in, and principal terms of, the Placing", each Placee will also have an immediate, separate, irrevocable and binding obligation, owed to the Joint Bookrunners, to pay to Panmure Gordon or Shore Capital (as the case maybe) (or as they shall each respectively direct) in cleared funds an amount equal to the product of the Issue Price and the number of Placing Shares which such Placees has agreed to acquire.

Each Placee and any person acting on behalf of such Placee agrees to indemnify on demand and hold each of the Joint Bookrunners and the Company, and their respective affiliates harmless from any costs, claims, liabilities and expenses (including legal fees and expenses) arising out of or in connection with any breach of the acknowledgments, undertakings, representations, warranties and agreements set forth in these terms and conditions and any contract note.

The Placing is also conditional upon the Placing Agreement becoming unconditional and the Placing Agreement not being terminated in accordance with its terms. Further details of conditions in relation to the Placing are set out below in the paragraph entitled "Conditions of the Placing". All obligations under the Placing will be subject to the fulfilment of the conditions referred to below in the paragraph entitled "Conditions of the Placing". 

To the fullest extent permitted by law, each Placee acknowledges and agrees that it will not be entitled to exercise any remedy of rescission at any time. This does not affect any other rights the Placee may have.

APPLICATION FOR ADMISSION TO TRADING

Application will be made to the London Stock Exchange for the Admission of the Placing Shares and Admission is expected to become effective at 8.00 a.m. on or around 9 June 2023 and dealings in the Placing Shares will commence at that time. 

Settlement of transactions in the Placing Shares following Admission will take place within the system administered by CREST, subject to certain exceptions. The Company reserves the right to require settlement for and delivery of the Placing Shares to Placees in certificated form if either of the Joint Bookrunners or the Company in its absolute discretion considers this to be necessary or desirable.

PAYMENT FOR SHARES

Each Placee has a separate, irrevocable and binding obligation to pay the Issue Price in cleared funds for the number of Placing Shares duly allocated to the Placee under the Placing in the manner and by the time directed by the Joint Bookrunners. If any Placee fails to pay as so directed and/or by the time directed, the relevant Placee's application for Placing Shares shall at the Joint Bookrunners' discretion either be rejected or accepted in which case the paragraph below entitled "Registration and Settlement" shall apply to such application.

PARTICIPATION IN, AND PRINCIPAL TERMS OF, THE PLACING

Each Joint Bookrunner (whether through itself or any of its affiliates) is arranging the Placing as placing agent of the Company and using its reasonable endeavours to procure Placees at the Issue Price for the Placing Shares.

Participation in the Placing will only be available to persons who may lawfully be, and are, invited to participate by the Joint Bookrunners. The Joint Bookrunners and its affiliates may participate in the Placing as principal.

By participating in the Placing, Placees will be deemed to have read and understood this announcement, including this Appendix, in its entirety and to be participating and making an offer for Placing Shares on the terms and conditions, and to be providing the representations, warranties, acknowledgements, agreements and undertakings contained in this Appendix.

This Appendix gives details of the terms and conditions of, and the mechanics of participation in, the Placing. No commissions will be paid to Placees or by Placees in respect of any Placing Shares.

The number of Placing Shares to be issued, and the extent of each Placee's participation in the Placing (which will not necessarily be the same for each Placee), will be agreed between the Joint Bookrunners and the Company following completion of the bookbuilding process in respect of the Placing (the "Bookbuild"). No element of the Placing will be underwritten. The aggregate number of Placing Shares will be announced on a Regulatory Information Service following completion of the Bookbuild.

A Placee's commitment to acquire a fixed number of Placing Shares under the Placing will be agreed orally or by email with a Joint Bookrunner as agent of the Company. Each Placee's allocation will be confirmed to Placees orally or by email by the relevant Joint Bookrunner, and a form of confirmation will be dispatched as soon as possible thereafter. The oral or email confirmation to such Placee will constitute an irrevocable legally binding commitment upon such person (who will at that point become a Placee) in favour of the Joint Bookrunners and the Company, under which it agrees to acquire the number of Placing Shares allocated to it at the Issue Price on the terms and conditions set out in this Appendix and in accordance with the articles of incorporation of the Company.

Except as required by law or regulation, no press release or other announcement will be made by the Joint Bookrunners or the Company using the name of any Placee (or its agent), in its capacity as Placee (or agent), other than with such Placee's prior written consent.

Irrespective of the time at which a Placee's allocation pursuant to the Placing is confirmed, settlement for all Placing Shares to be acquired pursuant to the Placing will be required to be made on the basis explained below under the paragraph entitled "Registration and Settlement".

All obligations under the Placing will be subject to fulfilment or (where applicable) waiver of, amongst other things, the conditions referred to below and to the Placing not being terminated on the basis referred to below.

By participating in the Placing, each Placee will agree that its rights and obligations in respect of the Placing will terminate only in the circumstances described below and will not be capable of rescission or termination by the Placee.

To the fullest extent permissible by law, none of the Company, the Joint Bookrunners or any of their respective affiliates shall have any liability to Placees (or to any other person whether acting on behalf of a Placee or otherwise under these terms and conditions). In particular, none of the Company, the Joint Bookrunners or any of its respective affiliates shall have any liability (including to the fullest extent permissible by law, any fiduciary duties) in respect of the Joint Bookrunners' conduct of the Placing. Each Placee acknowledges and agrees that the Company is responsible for the issue of the Placing Shares to the Placees and the Joint Bookrunners shall have no liability to the Placees for the failure of the Company to fulfil those obligations.

CONDITIONS OF THE PLACING

The Placing is conditional upon the Placing Agreement becoming unconditional and not having been terminated in accordance with its terms.

The Joint Bookrunners' obligations under the Placing Agreement (which are several and not joint, or joint and several) in respect of the Placing Shares are conditional on, inter alia:

1.    the passing of the Resolutions relating to the Placing, the Retail Offer and the Open Offer at the General Meeting;

2.    the Company allotting, subject only to Admission, the Placing Shares in accordance with the Placing Agreement;

3.    none of the warranties given by the Company in the Placing Agreement being untrue, inaccurate or misleading to an extent which would be material as at the date of the Placing Agreement or at any time between the date of the Placing Agreement and Admission;

4.    Admission having occurred by no later than 8.00 a.m. on or around 9 June 2023 or such later date as the Company and the Joint Bookrunners may agree, but in any event not later than the Placing Long Stop Date; and

5.    the Company having complied with its obligations under the Placing Agreement.

For the avoidance of doubt the Placing is not conditional on any of the Retail Offer, the Open Offer, the issuance of the Convertible Loan Notes or the Minimum Amount being raised  by the Fundraise.

If (a) any of the conditions contained in the Placing Agreement in relation to the Placing Shares are not fulfilled or waived by the Joint Bookrunners by the respective time or date where specified (or such later time or date as the Company and the Joint Bookrunners may agree not being later than 8.00 a.m. on 23 June 2023 (the "Placing Long Stop Date"); or (b) the Placing Agreement is terminated as described below, the Placing in relation to the Placing Shares will lapse and the Placee's rights and obligations hereunder in relation to the Placing Shares shall cease and terminate at such time and each Placee agrees that no claim can be made by the Placee in respect thereof.

Subject to certain exceptions, the Joint Bookrunners may, at their absolute discretion and upon such terms as they think fit, waive, or extend the period (up to the Placing Long Stop Date) for, compliance by the Company with the whole or any part of any of the Company's obligations in relation to the conditions in the Placing Agreement. Any such extension or waiver will not affect Placees' commitments as set out in this announcement.

Neither of the Joint Bookrunners nor the Company shall have any liability to any Placee (or to any other person whether acting on behalf of a Placee or otherwise) in respect of any decision they may make as to whether or not to waive or to extend the time and/or date for the satisfaction of any condition to the Placing nor for any decision they may make as to the satisfaction of any condition or in respect of the Placing generally and by participating in the Placing each Placee agrees that any such decision is within the absolute discretion of the Joint Bookrunners.

RIGHT TO TERMINATE UNDER THE PLACING AGREEMENT

Either Joint Bookrunners is entitled, at any time before Admission, to terminate the Placing Agreement by giving notice to the Company in certain circumstances, including, inter alia:

1.     the Company is in breach of any of its material obligations under the Placing Agreement or cannot comply with such material obligation; or

2.     any of the warranties given by the Company to the Joint Bookrunners under the Placing Agreement is, or if repeated at any time up to Admission would cause it to be, untrue, inaccurate or misleading in any material respect; or

3.     a matter having arisen prior to Admission in respect of which a claim for indemnification under the Placing Agreement may be sought;

4.     if, amongst other things, there is a substantial change in any national or international political, military, diplomatic, economic, financial or market conditions which in the Joint Bookrunner's opinion (acting in good faith and after such consultation with the Company or the other Joint Bookrunner as shall be practicable in the circumstances) would have or be likely to have a material and adverse effect on the Placing, the Retail Offer or Open Offer, or dealings in New Ordinary Shares in the secondary market or is of such magnitude to render the Fundraise, or the creation of a market in the New Ordinary Shares temporarily or permanently impracticable or inadvisable; or

5.     if it comes to the notice of the Joint Bookrunner that any statement contained in any Placing Document become untrue, inaccurate or misleading in any material respect or matters have arisen which would, if the Circular was issued at that time, constitute a material omission therefrom.

Following Admission, the Placing Agreement is not capable of termination to the extent it relates to the Placing of any of the Placing Shares.

The rights and obligations of the Placees shall terminate only in the circumstances described in these terms and conditions and in the Placing Agreement and will not be subject to termination by the Placee or any prospective Placee at any time or in any circumstances. By participating in the Placing, Placees agree that the exercise by a Joint Bookrunner of any right of termination or other discretion under the Placing Agreement shall be within the absolute discretion of such Joint Bookrunner and that it need not make any reference to Placees and that it shall have no liability to Placees whatsoever in connection with any such exercise or decision not to exercise. Placees will have no rights against the Joint Bookrunners, the Company or any of their respective directors or employees under the Placing Agreement pursuant to the Contracts (Rights of Third Parties) Act 1999 (as amended).

NO PROSPECTUS

The Placing Shares are being offered to Relevant Persons only and will not be offered in such a way as to require a prospectus in the United Kingdom or elsewhere under the Prospectus Regulation Rules Sourcebook published by the FCA. No offering document or prospectus has been or will be submitted to be approved by the FCA or any other party in relation to the Placing and Placees' commitments will be made solely on the basis of the information contained in this announcement (including this Appendix) and certain business and financial information the Company is required to publish in accordance with the Companies Act 2006, the AIM Rules and the rules and practices of the FCA (collectively "Exchange Information"), save that in the case of Exchange Information a Placee's right to rely on that information is limited to the right that such Placee would have as a matter of law in the absence of this paragraph.

Each Placee, by accepting a participation in the Placing, agrees that the content of this announcement, including this Appendix, is exclusively the responsibility of the Company and confirms that it has not relied on any other information (other than the Exchange Information), representation, warranty, or statement made by or on behalf of the Company or the Joint Bookrunners or any other person and neither of the Joint Bookrunners nor the Company nor any other person will be liable for any Placee's decision to participate in the Placing based on any other information, representation, warranty or statement which the Placees may have obtained or received. Each Placee acknowledges and agrees that it has relied on its own investigation of the business, financial or other position of the Company in accepting a participation in the Placing. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation.

REGISTRATION AND SETTLEMENT

Settlement of transactions in the Placing Shares (ISIN: GB00B11SZ269) following Admission will take place within the relevant system administered by Euroclear, being CREST provided that, subject to certain exceptions, the Joint Bookrunners reserve the right to require settlement for, and delivery of, the Placing Shares (or a portion thereof) to Placees by such other means that they deem necessary if delivery or settlement is not possible or practicable within CREST within the timetable set out in this announcement or would not be consistent with the regulatory requirements in any Placee's jurisdiction. The Company reserves the right to require settlement for and delivery of the Placing Shares to Placees in certificated form if any of the Joint Bookrunners or the Company in its absolute discretion considers this to be necessary or desirable.

Following the close of the Bookbuild, each Placee allocated Placing Shares in the Placing will be sent a form of confirmation stating the number of Placing Shares allocated to it at the Issue Price, the aggregate amount owed by such Placee to the relevant Joint Bookrunner (as agent for the Company) and settlement instructions (including the trade date which will be 19 May 2023). Each Placee agrees that it will do all things necessary to ensure that delivery and payment is completed in accordance with either the CREST or certificated settlement instructions that it has in place with the relevant Joint Bookrunner. Each Placee will also be sent a trade confirmation on the trade date (referred to above) confirming the details of the trade (being the acquisition of the relevant number of Placing Shares).

Admission and settlement may occur at an earlier date. Settlement will be on a delivery versus payment basis. However, in the event of any difficulties or delays in the admission of the Placing Shares to CREST or the use of CREST in relation to the Placing, the Company and the Joint Bookrunners may agree that the Placing Shares should be issued in certificated form. The Joint Bookrunners and the Company reserves the right to require settlement for the Placing Shares, and to deliver the Placing Shares to Placees, by such other means as they deem necessary if delivery or settlement to Placees is not practicable within the CREST system or would not be consistent with regulatory requirements in a Placee's jurisdiction.

Interest is chargeable daily on payments not received from Placees on the due date in accordance with the arrangements set out above at the rate of two percentage points above LIBOR as determined by the relevant the Joint Bookrunner.

Each Placee is deemed to agree that, if it does not comply with these obligations, the Joint Bookrunners (or either of them) may sell any or all of the Placing Shares allocated to that Placee on such Placee's behalf and retain from the proceeds, for the relevant the Joint Bookrunners' account and benefit (as agent for the Company), an amount equal to the aggregate amount owed by the Placee plus any interest due. Any excess proceeds will pass to the relevant Placee at its risk. The relevant Placee will, however, remain liable and shall indemnify the Joint Bookrunners on demand for any shortfall below the aggregate amount owed by it and may be required to bear any stamp duty or stamp duty reserve tax or securities transfer tax (together with any interest or penalties) which may arise upon the sale of such Placing Shares on such Placee's behalf. By communicating a bid for Placing Shares, each Placee confers on the Joint Bookrunners all such authorities and powers necessary to carry out any such sale and agrees to ratify and confirm all actions which the Joint Bookrunners lawfully takes in pursuance of such sale.

If Placing Shares are to be delivered to a custodian or settlement agent, Placees should ensure that the form of confirmation is copied and delivered immediately to the relevant person within that organisation.

Insofar as Placing Shares are registered in a Placee's name or that of its nominee or in the name of any person for whom a Placee is contracting as agent or that of a nominee for such person, such Placing Shares should, subject as provided below, be so registered free from any liability to UK stamp duty or stamp duty reserve tax or securities transfer tax. Placees will not be entitled to receive any fee or commission in connection with the Placing.

REPRESENTATIONS, WARRANTIES AND FURTHER TERMS

By submitting a bid and/or participating in the Placing, each Placee (and any person acting on such Placee's behalf) makes the following representations, warranties, acknowledgements, agreements and undertakings (as the case may be) to the Company and the Joint Bookrunners, namely that, each Placee (and any person acting on such Placee's behalf):

1.     represents and warrants that it has read and understood this announcement, including this Appendix, in its entirety and that its subscription for and purchase of the Placing Shares is subject to, and based upon, all the terms, conditions, representations, warranties, acknowledgements, agreements and undertakings and other information contained herein and undertakes not to redistribute or duplicate this announcement (including this Appendix);

2.     acknowledges that no offering document or prospectus has been prepared in connection with the placing of the Placing Shares and represents and warrants that it has not received and will not receive a prospectus, admission document or other offering document in connection therewith;

3.     acknowledges that the Ordinary Shares are admitted to trading on AIM, and the Company is therefore required to publish Exchange Information, which includes a description of the nature of the Company's business and the Company's most recent balance sheet and profit and loss account and that the Placee is able to obtain or access such information without undue difficulty, and is able to obtain access to such information or comparable information concerning any other publicly traded company, without undue difficulty;

4.     acknowledges that the content of this announcement (including this Appendix) is exclusively the responsibility of the Company, and that neither Joint Bookrunner, their respective affiliates or any person acting on their behalf has or shall have any liability for any information, representation or statement contained in this announcement (including this Appendix) or any information previously or concurrently published by or on behalf of the Company (including any Exchange Information), and will not be liable for any Placee's decision to participate in the Placing based on any information, representation or statement contained in this announcement (including this Appendix) or otherwise. Each Placee further represents, warrants and agrees that the only information on which it is entitled to rely and on which such Placee has relied in committing itself to acquire the Placing Shares is contained in this announcement (including this Appendix) and any Exchange Information (save that in the case of Exchange Information, a Placee's right to rely on that information is limited to the right that such Placee would have as a matter of law in the absence of this paragraph), such information being all that it deems necessary to make an investment decision in respect of the Placing Shares and that it has neither received nor relied on any other information given or representations, warranties or statements made by the Joint Bookrunners or the Company or any of their respective directors, officers or employees or any person acting on behalf of any of them (including with respect to the Company, the Placing, the Placing Shares or the accuracy, completeness or adequacy of any publicly available information), or, if received, it has not relied upon any such information, representations, warranties or statements, and neither of the Joint Bookrunners nor the Company will be liable for any Placee's decision to accept an invitation to participate in the Placing based on any other information, representation, warranty or statement. Each Placee further acknowledges and agrees that it may not place the same degree of reliance on this announcement as it may otherwise place on a prospectus or admission document. Each Placee further acknowledges and agrees that it has relied solely on its own investigation of the business, financial or other position of the Company and the terms of the Placing in deciding to participate in the Placing and it will not rely on any investigation that the Joint Bookrunners, their affiliates or any other person acting on their behalf has or may have conducted;

5.     represents and warrants that it has neither received nor relied on any confidential price sensitive information concerning the Company in accepting this invitation to participate in the Placing;

6.     time is of the essence as regards its obligations under this announcement;

7.     acknowledges that the Joint Bookrunners do not have any duties or responsibilities to it, or its clients, similar or comparable to the duties of "best execution" and "suitability" imposed by the Conduct of Business Sourcebook in the FCA's Handbook of Rules and Guidance and that neither Panmure Gordon nor Shore Capital is acting for it or its clients and that the Joint Bookrunners will not be responsible for providing protections to their respective clients;

8.     acknowledges that neither of the Joint Bookrunners, any of their affiliates or any persons acting on behalf of them has or shall have any liability for any publicly available or filed information (including any Exchange Information) or any representation relating to the Company, provided that nothing in this paragraph excludes the liability of any person for fraudulent misrepresentation made by that person;

9.     that, save in the event of fraud on the part of the relevant Joint Bookrunners (and to the extent permitted by the FCA), neither of the Joint Bookrunners, their respective ultimate holding companies nor any direct or indirect subsidiary undertakings of such holding companies, nor any of their respective directors and employees shall be liable to Placees for any matter arising out of either Joint Bookrunners' role as placing agent or otherwise in connection with the Placing and that where any such liability nevertheless arises as a matter of law, Placees will immediately waive any claim against any of such persons which it may have in respect thereof;

10.  represents and warrants that it is not a person located in the United States and is eligible to participate in an "offshore transaction" as defined in and in accordance with Regulation S and the Placing Shares were not offered to it by means of "directed selling efforts" as defined in Regulation S;

11.  unless otherwise specifically agreed in writing with the Joint Bookrunners, represents and warrants that neither it nor the beneficial owner of such Placing Shares will be a resident of an Excluded Territory;

12.  acknowledges that the Placing Shares have not been and will not be registered under the securities legislation of Excluded Territories and, subject to certain exceptions, may not be offered, sold, taken up, renounced or delivered or transferred, directly or indirectly, within those jurisdictions;

13.  that, in relation to any Placee located in Hong Kong, it is a professional investor as defined under the Securities and Futures Ordinance (Cap. 571);

14.  represents and warrants that the issue to it, or the person specified by it for registration as holder, of Placing Shares will not give rise to a liability under any of sections 67, 70, 93 or 96 of the Finance Act 1986 (depositary receipts and clearance services) and that the Placing Shares are not being acquired in connection with arrangements to issue depositary receipts or to transfer Placing Shares into a clearance system;

15.  represents and warrants that: (i) it has complied with and will continue to comply with its obligations under the Market Abuse Regulation (EU) No. 596/2014 (or the Market Abuse Regulation (EU) No. 596/2014 as retained in UK law), Criminal Justice Act 1993 and Part VIII of the Financial Services and Markets Act 2000, as amended ("FSMA") and other applicable law; (ii) in connection with money laundering and terrorist financing, it has complied with its obligations under the Proceeds of Crime Act 2002 (as amended), the Terrorism Act 2000 (as amended), the Terrorism Act 2006, the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) 2017 Regulations, and any other applicable law (where all such legislation listed under this (ii) shall together be referred to as the "AML Legislation"); and (iii) it is not a person: (1) with whom transactions are prohibited under the Foreign Corrupt Practices Act of 1977 or any economic sanction programmes administered by, or regulations promulgated by, the Office of Foreign Assets Control of the U.S. Department of the Treasury; (2) named on the Consolidated List of Financial Sanctions Targets maintained by HM Treasury of the United Kingdom; or (3) subject to financial sanctions imposed pursuant to a regulation of the EU or a regulation adopted by the United Nations (together, the "Regulations"); and, if making payment on behalf of a third party, that satisfactory evidence has been obtained and recorded by it to verify the identity of the third party as required by the Regulations and pursuant to AML Legislation and has obtained all governmental and other consents (if any) which may be required for the purpose of, or as a consequence of, such purchase, and it will provide promptly to the Joint Bookrunners or the Company such evidence, if any, as to the identity or location or legal status of any person (including in relation to the beneficial ownership of any underlying investor) which the Joint Bookrunners or the Company may request from it in connection with the Placing (for the purpose of complying with such Regulations or ascertaining the nationality of any person or the jurisdiction(s) to which any person is subject or otherwise or any other information as may be required to comply with legal or regulatory requirements (including in particular under the AML Legislation)) in the form and manner requested by the Joint Bookrunners or the Company on the basis that any failure by it to do so may result in the number of Placing Shares that are to be purchased by it or at its direction pursuant to the Placing being reduced to such number, or to nil, as the Joint Bookrunners and the Company may decide at their sole discretion;

16.  if a financial intermediary, as that term is used in Article 5(1) of the UK Prospectus Regulation, represents and warrants that the Placing Shares purchased by it in the Placing will not be acquired on a non-discretionary basis on behalf of, nor will they be acquired with a view to their offer or resale to, persons in a Member State of the EEA or the UK other than EU Qualified Investors or UK Qualified Investors respectively, or in circumstances in which the prior consent of the Joint Bookrunners has been given to the offer or resale;

17.  represents and warrants that it has not offered or sold and will not offer or sell any Placing Shares to persons in the EEA or the UK prior to Admission except to persons whose ordinary activities involve them in acquiring, holding, managing or disposing of investments (as principal or agent) for the purposes of their business or otherwise in circumstances which have not resulted in and which will not result in an offer to the public in any Member State of the EEA or the UK within the meaning of the EU Prospectus Regulation or UK Prospectus Regulation respectively;

18.  represents and warrants that it has only communicated or caused to be communicated and will only communicate or cause to be communicated any invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) relating to the Placing Shares in circumstances in which section 21(1) of the FSMA does not require approval of the communication by an authorised person;

19.  represents and warrants that it has complied and will comply with all applicable provisions of the FSMA and the Financial Services Act 2012 with respect to anything done by it in relation to the Placing Shares in, from or otherwise involving, the United Kingdom;

20.  if in the United Kingdom, represents and warrants that it is a UK Qualified Investor who: (i) falls with Articles 49(2)(A) to (D) or 19(5) of the Financial Promotion Order or (ii) it is a person to whom the Placing Shares may otherwise be lawfully offered under the Financial Promotion Order or, if it is receiving the offer in circumstances under which the laws or regulations of a jurisdiction other than the United Kingdom would apply, it is a person to whom the Placing Shares may be lawfully offered under that other jurisdiction's laws and regulations; and (iii) is a "professional client" or an "eligible counterparty" within the meaning of Chapter 3 of the FCA's Conduct of Business Sourcebook;

21.  represents and warrants that it and any person acting on its behalf is entitled to acquire the Placing Shares under the laws of all relevant jurisdictions and that it has all necessary capacity and has obtained all necessary consents and authorities and taken any other necessary actions to enable it to commit to this participation in the Placing and to perform its obligations in relation thereto (including, without limitation, in the case of any person on whose behalf it is acting, all necessary consents and authorities to agree to the terms set out or referred to in this announcement (including this Appendix)) and will honour such obligations;

22.  represents and warrants that it is not, and it is not acting on behalf of, a Sanctioned Shareholder;

23.  where it is acquiring Placing Shares for one or more managed accounts, represents and warrants that it is authorised in writing by each managed account: (i) to acquire the Placing Shares for each managed account; (ii) to make on its behalf the representations, warranties, acknowledgements, undertakings and agreements in this Appendix and the announcement of which it forms part; and (iii) to receive on its behalf any investment letter relating to the Placing in the form provided to it by a Joint Bookrunner;

24.  undertakes that it (and any person acting on its behalf) will make payment for the Placing Shares allocated to it in accordance with this announcement (including this Appendix) on the due time and date set out herein, failing which the relevant Placing Shares may be placed with other subscribers or sold as the Joint Bookrunners may in their sole discretion determine and without liability to such Placee and it will remain liable and will indemnify the Joint Bookrunners on demand for any shortfall below the net proceeds of such sale and the placing proceeds of such Placing Shares and may be required to bear the liability for any stamp duty or stamp duty reserve tax or security transfer tax (together with any interest or penalties due pursuant to or referred to in these terms and conditions) which may arise upon the placing or sale of such Placee's Placing Shares on its behalf;

25.  acknowledges that neither of the Joint Bookrunners, nor any of their respective affiliates, or any person acting on behalf of any of them, is making any recommendations to it, advising it regarding the suitability of any transactions it may enter into in connection with the Placing and that participation in the Placing is on the basis that it is not and will not be treated for these purposes as a client of either Joint Bookrunner and that either of the Joint Bookrunners does not have any duties or responsibilities to it for providing the protections afforded to their respective clients or customers or for providing advice in relation to the Placing nor in respect of any representations, warranties, undertakings or indemnities contained in the Placing Agreement nor for the exercise or performance of any of their rights and obligations thereunder, including any rights to waive or vary any conditions or exercise any termination right;

26.  undertakes that the person whom it specifies for registration as holder of the Placing Shares will be (i) itself; or (ii) its nominee, as the case may be. Neither of the Joint Bookrunners nor the Company will be responsible for any liability to stamp duty or stamp duty reserve tax resulting from a failure to observe this requirement. Each Placee and any person acting on behalf of such Placee agrees to participate in the Placing and it agrees to indemnify the Company and the Joint Bookrunners in respect of the same on the basis that the Placing Shares will be issued to the CREST stock account of a Joint Bookrunner who will hold them as nominee on behalf of such Placee until settlement in accordance with its standing settlement instructions;

27.  acknowledges that these terms and conditions and any agreements entered into by it pursuant to these terms and conditions and any non-contractual obligations arising out of or in connection with such agreement shall be governed by and construed in accordance with the laws of England and it submits (on behalf of itself and on behalf of any person on whose behalf it is acting) to the exclusive jurisdiction of the English courts as regards any claim, dispute or matter (including non-contractual matters) arising out of any such contract, except that enforcement proceedings in respect of the obligation to make payment for the Placing Shares (together with any interest chargeable thereon) may be taken by the Company or a Joint Bookrunner in any jurisdiction in which the relevant Placee is incorporated or in which any of its securities have a quotation on a recognised stock exchange;

28.  agrees that the Company, the Joint Bookrunners and their respective affiliates and others will rely upon the truth and accuracy of the foregoing representations, warranties, acknowledgements and undertakings which are given to each of the Joint Bookrunners on its own behalf and on behalf of the Company and are irrevocable and are irrevocably authorised to produce this announcement or a copy thereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby;

29.  agrees to indemnify on an after-tax basis and hold the Company, the Joint Bookrunners and their respective affiliates harmless from any and all costs, claims, liabilities and expenses (including legal fees and expenses) arising out of or in connection with any breach of the representations, warranties, acknowledgements, agreements and undertakings in this Appendix and that the provisions of this Appendix shall survive after completion of the Placing and, further agrees if any of the foregoing is or becomes no longer true or accurate, the Placee shall promptly notify the Company and the Joint Bookrunners;

30.  acknowledges that no action has been or will be taken by any of the Company, the Joint Bookrunners or any person acting on behalf of the Company or the Joint Bookrunners that would, or is intended to, permit a public offer of the Placing Shares in any country or jurisdiction where any such action for that purpose is required;

31.  acknowledges that it is an institution that has knowledge and experience in financial, business and international investment matters as is required to evaluate the merits and risks of subscribing for the Placing Shares. It further acknowledges that it is experienced in investing in securities of this nature and in this sector and is aware that it may be required to bear, and it, and any accounts for which it may be acting, are able to bear, the economic risk of, and is able to sustain, a complete loss in connection with the Placing. It has relied upon its own examination and due diligence of the Company and its associates taken as a whole, and the terms of the Placing, including the merits and risks involved;

32.  acknowledges that its commitment to subscribe for Placing Shares on the terms set out herein will continue, notwithstanding any amendment that may in the future be made to the terms of the Placing and that Placees will have no right to be consulted or require that their consent be obtained with respect to the Company's conduct of the Placing;

33.  acknowledges that a Joint Bookrunner or any of its affiliates acting as an investor for its own account may take up shares in the Company and in that capacity may retain, purchase or sell for its own account such shares and may offer or sell such shares other than in connection with the Placing;

34.  represents and warrants that, if it is a pension fund or investment company, its purchase of Placing Shares is in full compliance with all applicable laws and regulation; and

35.  to the fullest extent permitted by law, it acknowledges and agrees to the disclaimers contained in the announcement, including this Appendix.

The representations, warranties, acknowledgments and undertakings contained in this Appendix are given to the Joint Bookrunners and the Company and are irrevocable and shall not be capable of termination in any circumstances.

The agreement to settle a Placee's subscription (and/or the subscription of a person for whom such Placee is contracting as agent) free of stamp duty and stamp duty reserve tax depends on the settlement relating only to a subscription by it and/or such person direct from the Company for the Placing Shares in question. Such agreement assumes that the Placing Shares are not being subscribed for in connection with arrangements to issue depositary receipts or to transfer the Placing Shares into a clearance service. If there are any such arrangements, or the settlement relates to any other subsequent dealing in the Placing Shares, stamp duty or stamp duty reserve tax may be payable, for which neither the Company nor the Joint Bookrunners will be responsible, and the Placee to whom (or on behalf of whom, or in respect of the person for whom it is participating in the Placing as an agent or nominee) the allocation, issue or delivery of Placing Shares has given rise to such UK stamp duty or stamp duty reserve tax undertakes to pay such UK stamp duty or stamp duty reserve tax forthwith and to indemnify on an after-tax basis and to hold harmless the Company and the Joint Bookrunners in the event that any of the Company and/or the Joint Bookrunners has incurred any such liability to UK stamp duty or stamp duty reserve tax. If this is the case, each Placee should seek its own advice and notify the Joint Bookrunners accordingly.

In addition, Placees should note that they will be liable for any stamp duty and all other stamp, issue, securities, transfer, registration, documentary or other duties or taxes (including any interest, fines or penalties relating thereto) payable outside the UK by them or any other person on the subscription by them of any Placing Shares or the agreement by them to subscribe for any Placing Shares.

Each Placee, and any person acting on behalf of the Placee, acknowledges that the Joint Bookrunners does not owe any fiduciary or other duties to any Placee in respect of any representations, warranties, undertakings or indemnities in the Placing Agreement.

Each Placee and any person acting on behalf of the Placee acknowledges and agrees that the Joint Bookrunners or any of their affiliates may, at their absolute discretion, agree to become a Placee in respect of some or all of the Placing Shares.

When a Placee or person acting on behalf of the Placee is dealing with a Joint Bookrunner any money held in an account with such Joint Bookrunner on behalf of the Placee and/or any person acting on behalf of the Placee will not be treated as client money within the meaning of the rules and regulations of the FCA made under the FSMA. The Placee acknowledges that the money will not be subject to the protections conferred by the client money rules; as a consequence, this money will not be segregated from the relevant Joint Bookrunners' money in accordance with the client money rules and will be used by that Joint Bookrunner in the course of its own business and the Placee will rank only as a general creditor of that Joint Bookrunner.

All times and dates in this announcement (including this Appendix) may be subject to amendment, and Placees' commitments, representations and warranties are not conditional on any of the expected times and dates in this announcement (including this Appendix) being achieved. The Joint Bookrunners shall notify the Placees and any person acting on behalf of the Placees of any changes.

Past performance is no guide to future performance and persons needing advice should consult an appropriately qualified independent financial adviser.

A Joint Bookrunner is entitled, at its discretion and out of its own resources, at any time to rebate to some or all of its investors, or to other parties, part or all of its fees relating to the Placing.

MISCELLANEOUS

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures, each as they form part of the law of England and Wales by virtue of EUWA (together, the "Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that the Placing Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, Placees should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Joint Bookrunners will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or Company of investors to invest in, or purchase, or take any other action whatsoever with respect to the Placing Shares.

Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

The content of this announcement has been issued by, and is the sole responsibility of, Velocys plc.

The information contained in this announcement is given at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment from time to time. Neither the content of the Company's website nor any website accessible by hyperlinks to the Company's website is incorporated in, or forms part of, this announcement.

Panmure Gordon (UK) Limited, which is authorised and regulated in the United Kingdom by the FCA, is acting as nominated adviser, joint bookrunner and joint broker to the Company in connection with the Placing and Admission and to no-one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, nor for providing advice in relation to the Placing or Admission or any other matter referred to in this announcement. Panmure Gordon's responsibilities as the Company's nominated adviser under the AIM Rules for Nominated Advisers are owed solely to London Stock Exchange plc and are not owed to the Company or to any director of the Company or to any other person in respect of any decision to acquire shares in the Company in reliance on any part of this announcement.

Shore Capital Group Limited, which is authorised and regulated in the United Kingdom by the FCA, is acting as joint bookrunner and joint broker to the Company in connection with the Placing and Admission and to no-one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, nor for providing advice in relation to the Placing or Admission or any other matter referred to in this announcement.

Neither of the Joint Bookrunners or any of their directors, officers, employees, advisers, affiliates or agents, accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or for any loss howsoever arising from any use of the announcement or its contents. The Joint Bookrunners and their respective directors, officers, employees, advisers, affiliates or agents, accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this announcement or its contents or otherwise arising in connection therewith.

Data Protection

The processing of a Placee's personal data by the Company will be carried out in compliance with the applicable data protection legislation and with its Privacy Notice, a copy of which can be found on the Company's website https://www.velocys.com/privacy-policy/.

Each Placee acknowledges that it has read and understood the processing activities carried out by the Company as informed in the referred Privacy Notice.

APPENDIX III

DEFINITIONS AND GLOSSARY

DEFINITIONS

The following definitions apply throughout this announcement unless the context otherwise requires:

GLOSSARY

The terms set out below have the following meanings throughout this announcement, unless the context requires otherwise.

APPENDIX IV

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

(1)             References to are to London time (unless otherwise stated).

(2)             The dates and timing of the events in the above timetable and in the Circular are indicative only and may be subject to change.

(3)             If any of the above times or dates should change, the revised times and/or dates will be notified by an announcement through a Regulatory Information Service.

(4)             This is subject to satisfaction of the conditions in the Commitment Letter

(5)             This date can be extended to 31 December 2023 with the agreement of the Company and Carbon Direct Capital